Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E26.95 EPS (ttm)1.16 Insider Own0.50% Shs Outstand2.53B Perf Week2.94%
Market Cap78.70B Forward P/E13.84 EPS next Y2.25 Insider Trans0.00% Shs Float2.50B Perf Month8.47%
Income2.92B PEG- EPS next Q0.76 Inst Own11.00% Short Float1.01% Perf Quarter3.42%
Sales24.77B P/S3.18 EPS this Y128.90% Inst Trans1.35% Short Ratio5.00 Perf Half Y2.09%
Book/sh5.83 P/B5.34 EPS next Y-4.50% ROA5.00% Target Price34.66 Perf Year-2.13%
Cash/sh1.62 P/C19.20 EPS next 5Y-1.00% ROE17.00% 52W Range26.97 - 33.79 Perf YTD-5.34%
Dividend1.90 P/FCF- EPS past 5Y-16.70% ROI11.50% 52W High-7.86% Beta0.69
Dividend %6.10% Quick Ratio0.70 Sales past 5Y-5.80% Gross Margin82.80% 52W Low15.42% ATR0.53
Employees61500 Current Ratio0.80 Sales Q/Q1.00% Oper. Margin17.00% RSI (14)66.55 Volatility1.29% 1.62%
OptionableYes Debt/Eq1.11 EPS Q/Q17.50% Profit Margin11.80% Rel Volume2.54 Prev Close30.53
ShortableYes LT Debt/Eq0.96 EarningsJul 28 BMO Payout121.20% Avg Volume5.05M Price31.13
Recom2.60 SMA204.12% SMA506.39% SMA2003.34% Volume12,318,300 Change1.97%
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-08-16Downgrade HSBC Securities Buy → Hold
Jan-19-16Upgrade Barclays Underweight → Equal Weight
Dec-01-15Upgrade Morgan Stanley Underweight → Overweight
Nov-02-15Downgrade Nordea Buy → Hold
Oct-20-15Downgrade Credit Suisse Neutral → Underperform
Sep-18-15Upgrade Bryan Garnier Neutral → Buy
Jul-31-15Upgrade Swedbank Neutral → Buy
Jul-02-15Upgrade Berenberg Hold → Buy
Apr-15-15Initiated Societe Generale Buy
Sep-22-10Reiterated Barclays Capital Equal Weight $225 → $230
Jul-29-10Downgrade Standpoint Research Buy → Hold $60
Jun-30-10Upgrade Jefferies Underperform → Hold
Jan-13-10Upgrade Credit Suisse Underperform → Neutral
Nov-16-09Initiated Deutsche Securities Hold
Nov-12-09Initiated Barclays Capital Equal Weight
Nov-09-09Downgrade JP Morgan Neutral → Underweight
Jul-24-16 11:48AM  [$$] New drugs aim to kill cancer cells by destabilising their DNA at Financial Times
Jul-22-16 12:58PM  European Stock Markets Mixed After Signs of Brexit Damage
Jul-21-16 04:20PM  Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly at Motley Fool
04:16PM  Relypsa Getting Acquired By Swiss Partner Seeking U.S. Entry
12:05PM  Why Shares of Relypsa Are Soaring Today at Motley Fool
Jul-20-16 08:42AM  Your inhaler's watching you: drugmakers race for smart devices Reuters
01:20AM  Indian Firms Get Approval for Generics of AstraZeneca Drug at Bloomberg
Jul-19-16 06:58PM  Judge refuses to block generic versions of AstraZeneca's Crestor Reuters
06:54PM  AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
05:51PM  AstraZeneca Fails to Keep Generic Crestor Rivals Off Market at Bloomberg
04:27PM  FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis PR Newswire
04:27PM  FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis CNW Group
Jul-18-16 06:49PM  Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
10:04AM  Is This Gilead Sciences' Most Underappreciated Drug Candidate? at Motley Fool
07:22AM  AstraZeneca lung cancer drug meets late-stage trial endpoint at MarketWatch
07:12AM  TAGRISSO® (OSIMERTINIB) Met Primary Endpoint in Phase III 2nd-Line Lung Cancer Trial Business Wire
02:23AM  AstraZeneca's lung cancer drug meets main goal in late-stage trial
Jul-14-16 01:15PM  3 Dividend Aristocrats to Avoid at Motley Fool
07:30AM  Don't Wrap a Union Jack Around U.K. Plc at Bloomberg
Jul-13-16 11:27AM  AstraZeneca Plans to Step into the Medivation Battle: a Threat for Sanofi?
09:55AM  AstraZeneca (AZN) Stock Advancing on Patent Litigation Resolution
08:23AM  Theresa May to be Appointed New U.K. Prime Minister
Jul-12-16 03:27PM  AstraZeneca (AZN) Stock Up, Argus Research Initiates Coverage
02:44PM  Why Relypsa Stock Is Ripping
12:21PM  FTSE 100 closes little-changed as rise in pound weighs on exporters at MarketWatch
10:25AM  Sage Therapeutics' Post-Partum Depression Drug Scores; Stock Up
07:42AM  Coverage initiated on AstraZeneca by Argus
Jul-11-16 09:02AM  May Says U.K. Must Defend Its Drugmakers From Overseas Takeovers at Bloomberg
Jul-08-16 04:09PM  A Look Inside the iShares International Select Dividend ETF (IDV, AZN) at Investopedia
01:43PM  Why AstraZeneca PLC Stock Rose in June at Motley Fool
10:47AM  How Will AstraZeneca (AZN) Stock Be Affected by Generic Copies?
Jul-06-16 03:38PM  Why Has Brexit Been Bad for Biopharma? at Motley Fool
10:59AM  Valeant (VRX) Loses European Rights to Psoriasis Candidate
09:39AM  AstraZeneca Skin Drug, Tralokinumab, Rights Licensed to LEO
04:12AM  Initiation of Phase 1 Clinical Study with Novel Immuno-Oncology Candidate Triggers US$10 Million Milestone Payment from AstraZeneca to Heptares Business Wire
Jul-05-16 05:30PM  Medivation Agrees To Work With Sanofi After Nixing Higher Bid
12:56PM  FTSE 100 trudges higher, but banks, property stocks get hit at MarketWatch
12:16PM  Is Biopharma Immune to Brexit Fallout? at Motley Fool
Jul-04-16 10:38AM  5 Trade Ideas for Tuesday: AstraZeneca, BRF SA, Cerner, Ironwood Pharma and Marathon Oil
Jul-02-16 06:44AM  How Post-Brexit Currency Fluctuations Could Affect U.S. ADR Holders at Motley Fool
Jul-01-16 04:08PM  AstraZeneca Transfers Valeant's European Rights To Troubled Drug
03:40PM  An Overnight Double! Could These Drugmakers Be Next? at Motley Fool
12:07PM  Understanding Pfizers Growth Contributors
02:00AM  Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe PR Newswire
Jun-30-16 04:24PM  Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016 at Motley Fool
11:01AM  [$$] Who Will Acquire Medivation? at Barrons.com
Jun-29-16 09:56AM  Tesaro Stock Bolts On Surprise Win For Ovarian Cancer Drug
08:00AM  AstraZenecas cholesterol-drug gambit is the latest tactic from a company skilled at them
Jun-28-16 06:30PM  Which Biotechnology Companies Could Benefit from Brexit?
12:24PM  ACADIA Pharmaceuticals Inc.'s Shareholders Are Having a Crazy Year. Here's Why at Motley Fool
11:28AM  After Brexit, Investors Should Keep Calm and Carry On
09:09AM  Could Novo Nordisks 2016 Earnings Impress Wall Street?
12:35AM  PRESS DIGEST- New York Times business news - June 28
Jun-27-16 08:10PM  Brexit Continues to Pressure U.S. Stocks at MarketWatch
12:23PM  Evaluating Novo Nordisks Efficiency Based on EV-to-EBITDA
12:23PM  Novo Nordisks Premium Valuation Based on Price-to-Earnings
08:03AM  6 ways Brexit could impact Washington business at bizjournals.com
Jun-24-16 01:24PM  The Brexit Vote Is Crushing These 3 Clinical-Stage Biotech Stocks at Motley Fool
01:06PM  Post-Brexit Analysis: Should Investors Buy or Sell Biopharma? at Motley Fool
12:50PM  Post-Brexit opportunities in three British stocks at MarketWatch
Jun-23-16 05:01PM  Sanofi's Likely Sweetener for Medivation Panned
04:00PM  AstraZeneca Likely to Grind Lower
02:00PM  U.S. spurns AstraZeneca's nasal spray flu vaccine as ineffective Reuters
01:07PM  AstraZeneca, Teva Resolve Their Patent Row Over Diabetes Product
10:00AM  Teva, AstraZeneca settle patent dispute over multimillion-dollar drug at bizjournals.com
09:15AM  AstraZeneca Nasal Spray Flu Vaccine To be Hit By ACIP Vote
02:45AM  AstraZeneca takes $80 mln hit as U.S. spurns nasal flu vaccine Reuters
02:45AM  CDC Advises Against Using AstraZenecas FluMist Next Season at Bloomberg
Jun-22-16 07:56AM  Sell These 5 U.K. Stocks Now Before the Brexit Vote
Jun-21-16 03:03PM  7 Pharmaceutical Stocks With Dividends Yielding More Than 3% at Motley Fool
Jun-20-16 01:44PM  How to Short the FTSE Ahead of The Brexit Vote at Investopedia
01:01PM  This New Class Of Medicine Could Reshape Diabetes Treatment at Motley Fool
12:07AM  [$$] Secret Deal Squeezes Mexicos Drug Sector at The Wall Street Journal
Jun-19-16 08:29PM  [$$] Secret Deal Squeezes Mexico's Drug Sector at The Wall Street Journal
07:50PM  [$$] Secret Deal Squeezes Mexico Drug Sector at The Wall Street Journal
Jun-15-16 04:46PM  Relypsa Sales Numbers Surprise to the Upside
09:20AM  Perrigo Rises Further as Takeover Rumor Swirls
Jun-14-16 01:35PM  Call buyers take a dose of AstraZeneca
08:00AM  AstraZeneca Introduces AZhelps, an Innovative Savings and Support Program to Help Patients with Their Medicines Business Wire
07:22AM  Here's Why Novavax's Stock Could Double at Motley Fool
Jun-13-16 02:46PM  Eli Lilly Names New CIO at The Wall Street Journal
08:30AM  With Brexit Looming, Hedge Funds Weigh In On British Stocks at Insider Monkey
Jun-11-16 11:00AM  AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes Business Wire
11:00AM  AstraZeneca Presents Findings from Two Pooled Analyses at the 76th Scientific Sessions of the American Diabetes Association Evaluating Dapagliflozin in Type 2 Diabetes Patients with Renal Impairment and in Combination with Potassium-Sparing Business Wire
Jun-10-16 11:31AM  Ironwood/Allergan's Linzess sNDA Accepted for FDA Review
11:15AM  AstraZeneca Monetizes Anesthetics Marketing for $770 million (AZN) at Investopedia
10:19AM  [$$] Bristol-Myers, a Top Pharmaceuticals Pick at Barrons.com
Jun-09-16 05:40PM  Valeant To Participate In FDA Advisory Committee Meeting On July 19 PR Newswire
11:15AM  $770M deal: AstraZeneca sells rights to 7 anesthetic products at bizjournals.com
09:12AM  AstraZeneca (AZN) Stock Slides After Selling Rights to Anesthetics
03:58AM  AstraZeneca sells rights to anesthetics for up to $770 million
02:22AM  AstraZeneca sells rights to anaesthetics to South Africa's Aspen
Jun-08-16 12:06PM  What Are the Changes in AstraZenecas Profitability?
08:00AM  AstraZeneca to Highlight Scientific Advancements Across Its Diabetes Portfolio at the American Diabetes Association 76th Scientific Sessions Business Wire
Jun-07-16 11:51AM  AstraZeneca Presents Tagrisso Leptomeningeal Disease Data
07:59AM  Another Strike Against TV Drug Ads: Opioid-Induced Constipation at Forbes
Jun-06-16 04:30PM  Why Shares of ACADIA Pharmaceuticals Inc. Jumped Today at Motley Fool
01:20PM  Relypsa: Largest Institutional Shareholders are Buying More Stock
12:38PM  Tagrisso (Osimertinib) Shows Clinical Activity in Patients with Leptomeningeal Disease from Lung Cancer Business Wire
09:07AM  AstraZenecas Key Focus: Oncology
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide. Its marketed products comprise Accolate, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp, Duaklir Genuair, Eklira Genuair/Tudorza/Bretaris, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Rhinocort, Symbicort pMDI, and Symbicort Turbuhaler for respiratory, inflammation, and autoimmunity diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL, Tenormin3, and Zestril4 for cardiovascular disease; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic disease. The company's marketed products also include Arimidex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex, as well as Casodex, Cosudex for oncology disease; Fluenz/FluMist, Fluenz Tetra/FluMist Quadrivalent1, Merrem/Meronem2, Synagis3, and Zinforo4 for infection disease; Diprivan, EMLA, Movantik/Moventig, Naropin, Seroquel IR, Seroquel XR, Vimovo1, Xylocaine, and Zomig for neuroscience disease; and Losec/Prilosec and Nexium for gastrointestinal disease. It primarily serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 146 projects, of which 125 are in the clinical phase of development. It has collaboration agreements with Celgene Corporation; Immunocore Limited; Eli Lilly and Company; Heptares Ltd.; Foundation Medicine, Inc., French National Institute of Health and Medical Research (Inserm); and FibroGen and Astellas. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.
EBAY eBay Inc. daily Stock Chart
EBAY [NASD]
eBay Inc.
IndexS&P 500 P/E18.21 EPS (ttm)1.67 Insider Own7.30% Shs Outstand1.13B Perf Week15.76%
Market Cap34.39B Forward P/E14.67 EPS next Y2.08 Insider Trans-0.25% Shs Float1.07B Perf Month25.27%
Income1.99B PEG3.17 EPS next Q0.44 Inst Own84.70% Short Float1.82% Perf Quarter24.96%
Sales8.79B P/S3.91 EPS this Y330.80% Inst Trans0.20% Short Ratio1.70 Perf Half Y15.36%
Book/sh5.64 P/B5.41 EPS next Y10.47% ROA10.20% Target Price31.15 Perf Year7.25%
Cash/sh7.17 P/C4.25 EPS next 5Y5.74% ROE29.90% 52W Range21.52 - 30.31 Perf YTD10.95%
Dividend- P/FCF11.95 EPS past 5Y3.30% ROI13.00% 52W High0.59% Beta1.10
Dividend %- Quick Ratio4.50 Sales past 5Y-1.30% Gross Margin78.40% 52W Low41.68% ATR0.75
Employees11600 Current Ratio4.50 Sales Q/Q-46.50% Oper. Margin27.10% RSI (14)88.31 Volatility2.70% 2.22%
OptionableYes Debt/Eq0.00 EPS Q/Q-46.80% Profit Margin22.00% Rel Volume1.82 Prev Close29.93
ShortableYes LT Debt/Eq1.40 EarningsJul 20 AMC Payout0.00% Avg Volume11.44M Price30.49
Recom2.50 SMA2022.51% SMA5025.23% SMA20020.12% Volume20,258,200 Change1.87%
Jul-21-16Reiterated The Benchmark Company Buy $29 → $33
Jul-21-16Reiterated RBC Capital Mkts Sector Perform $28 → $31
Jul-21-16Reiterated Monness Crespi & Hardt Buy $29 → $32
Jul-21-16Reiterated Mizuho Neutral $26 → $31
Jul-21-16Reiterated Canaccord Genuity Hold $27 → $28
Jul-21-16Reiterated Axiom Capital Buy $30 → $34
Jun-23-16Initiated Maxim Group Buy $36
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $29 → $28
Apr-19-16Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-29-16Downgrade Barclays Equal Weight → Underweight $28 → $25
Feb-16-16Reiterated Axiom Capital Buy $34 → $30
Jan-28-16Reiterated The Benchmark Company Buy $29 → $28
Jan-28-16Reiterated RBC Capital Mkts Sector Perform $30 → $29
Jan-28-16Reiterated Monness Crespi & Hardt Buy $31 → $29
Jan-28-16Reiterated Canaccord Genuity Hold $28 → $26
Jan-15-16Initiated Susquehanna Positive $34
Oct-22-15Reiterated Topeka Capital Markets Buy $68 → $32
Oct-22-15Reiterated RBC Capital Mkts Sector Perform $29 → $30
Oct-22-15Reiterated Mizuho Neutral $30 → $29
Sep-24-15Reiterated JP Morgan Neutral $33 → $32
Jul-23-16 06:55PM  eBay, AMD Head the List of Nasdaq Stocks Hitting 52-Week Highs Friday at Insider Monkey
01:11PM  3 Key Lessons From Netflix, Domino's Pizza: IBD Investing Show
Jul-22-16 04:49PM  Who Won and Lost on the Nasdaq This Week? Bloomberg TV Weighs In at TheStreet
04:39PM  Who Got Best Of Visa-PayPal Deal? 'Too Early To Tell'
02:04PM  eBay: 2Q16 Top Line Driven by StubHub and Classifieds
11:49AM  eBay, Inc. :EBAY-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016
07:16AM  eBay getting slight boost from Brexit at MarketWatch
01:03AM  What Drove eBays 2Q16 Bottom Line?
Jul-21-16 09:31PM  EBay's plan to stay relevant: Artificial intelligence at CNBC +10.89%
06:03PM  Stocks Lose Steam; Breakouts From eBay, Domino's
05:12PM  EBay Stock Hits Record High As Earnings Hint At 'Cash Cougar'
05:10PM  EBAY INC Files SEC form 10-Q, Quarterly Report
05:00PM  Biz Break: eBay shines after results; smartwatch sales retreat at Silicon Beat
04:56PM  eBay Is No Amazon, But It's In Better Shape Than Before
04:52PM  Stock Market Today: eBay and Dominos Jump as the Broad Market Declines at Motley Fool
04:40PM  PayPal Posts 15% Rise In Second Quarter Sales, Partners With Visa at Forbes
04:30PM  Qualcomm, Halliburton, eBay, Intel Price Targets Raised After Earnings
03:54PM  Google: Currency Headwinds Could Impact the Top Line
03:42PM  EBay Rewards Investors Following 2Q Earnings and Upbeat Guidance
03:10PM  eBay's (EBAY) Q2 Earnings and Revenues Beat Estimates
02:23PM  Street Talk: Chesapeake Energy, WPX Energy and more
02:18PM  EBay's stock soar to record high on heavy volume at MarketWatch
02:12PM  EBay Sees a 2Q Benefit from Brexit-Related Currency Fluctuations
12:37PM  Why eBay, Inc. Stock Soared Today at Motley Fool
12:16PM  eBay Headed For New Highs (EBAY, AMZN) at Investopedia
12:14PM  Midday Report: Existing Home Sales at Best Since 2007; U.S. Stocks Mixed at TheStreet
12:00PM  EBay: Better-Than-Expected Results Lead to Modest Fair Value Increase at Morningstar
11:13AM  eBay Soars 10%, Analysts Parse Q2 Earnings at Barrons.com
11:12AM  EBay Jumps Most in Nine Months After Raising 2016 Earnings Goal
11:12AM  eBay CEO Wenig Discusses Earnings and Artificial Intelligence on CNBC
11:07AM  Tech earnings recap: INTC, EBAY & QCOM
10:42AM  eBay Stock Advancing After Q2 Earnings Beat
10:40AM  Analysts Get Much More Bullish on eBay, Growth Avenues Ahead of Value at 24/7 Wall St.
10:15AM  Guidance can provide transparency: eBay CEO
10:10AM  EBay's strengths: CEO Wenig
09:45AM  Stock Open Mixed; Qualcomm, Joy Global Rocket
09:34AM  Stocks to Watch: Tesla, GM, Joy Global, Intel, EBay, Biogen at The Wall Street Journal
09:30AM  The Zacks Analyst Blog Highlights: Intel, American Express, Qualcomm and eBay
08:45AM  Top Analyst Upgrades and Downgrades: American Express, AT&T, eBay, Intel, Qualcomm, Teradyne and Many More at 24/7 Wall St.
08:25AM  Todays Hot Stocks: Exxon, Kinder Morgan, eBay, More at Insider Monkey
07:40AM  eBay Jumps on Q2 Earnings: ETFs to Play
04:50AM  Edited Transcript of EBAY earnings conference call or presentation 20-Jul-16 9:00pm GMT
Jul-20-16 06:44PM  EBay beats revenue estimate, bumps up forecasts
06:41PM  While Growth Stalls on eBays Marketplace, StubHub Skyrockets at Fortune
06:30PM  eBay, Inc. Picks Up the Pace at Motley Fool
06:04PM  [$$] EBay Again Posts Sales Gains at The Wall Street Journal
05:50PM  Bevy of Q2 Earnings Continues: INTC, EBAY, AXP, QCOM & MAT
05:37PM  eBay (EBAY) Beats Q2 Earnings, Up 5.5% on Raised Guidance
05:25PM  EBay Q2 Earnings Beat Estimates, Stock Jumps Late
05:00PM  eBay Earnings Beat Street in Q2, Raises Guidance at TheStreet
04:40PM  EBay revenue rises 5.7 percent
04:32PM  eBay Stock Gaining on Q2 Earnings and Revenue Beat
04:26PM  EBay Raises Forecasts a Year After PayPal Split at Bloomberg
04:26PM  EBay beats Street 2Q forecasts
04:26PM  eBay shares soar amid earnings beat, further stock buybacks at MarketWatch
04:22PM  EBay revenue rises 5.7 pct
04:18PM  eBay Jumps On Upbeat Q2 Earnings, Revenues; Raises Forecast at Barrons.com
04:17PM  EBAY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:15PM  eBay Inc. Reports Second Quarter 2016 Results Business Wire
02:35PM  Will eBays earnings be as terrible as social data suggests?
10:31AM  Can General Motors Turn On Cruise Control With Latest Acquisition? at Forbes
09:52AM  Amazon, Yahoo, and a Tech Earnings Season Primer
09:30AM  What to expect from eBay earnings at MarketWatch
09:30AM  The Zacks Analyst Blog Highlights: eBay, Amazon, Expedia, Autobytel and Blue Nile
09:04AM  What Are Analysts Recommendations for Amazon?
08:16AM  [$$] EBay Earnings: What to Watch at The Wall Street Journal
07:07AM  Q2 2016 eBay Inc Earnings Release - After Market Close
12:16AM  [$$] eBay Shares Are Worth Bidding On at The Wall Street Journal
Jul-19-16 09:34PM  A Look at eBay Ahead of Q2 Earnings at Investopedia
05:23PM  Technology Stocks to Watch This Earnings Season: MSFT, P, EBAY
04:30PM  Can this Online Marketplace Compete with Amazon?
04:30PM  What To Expect When eBay Reports Q2 Earnings
03:23PM  [$$] EBay Shares Are Worth Bidding On at The Wall Street Journal
01:55PM  Amazon Hammered for Counterfeit Sales at 24/7 Wall St.
01:33PM  [$$] Zenreach Launches With $50M for Small-Business Marketing Via Free Wi-Fi at The Wall Street Journal
01:00PM  Slack Taps $80 Million Fund to Invest In More Startups at Fortune
12:20PM  What's Ahead For These eCommerce Stocks In Q2 Earnings?
09:05AM  Is Amazon Set to Deliver Another Earnings Surprise?
09:00AM  5 Stocks to Watch this Week 7/18: MSFT, INTC, EBAY, SBUX, CMG
Jul-18-16 03:11PM  What to Expect When eBay Posts Q2 Results
02:59PM  What's in Store for eBay Inc. (EBAY) This Earnings Season?
01:30AM  [$$] Pokémon Go Players Cash In at The Wall Street Journal
Jul-17-16 11:41PM  [$$] 'Pokémon Go' Players Cash In at The Wall Street Journal
10:10AM  9 Top Earnings to Watch for in the Week Ahead at 24/7 Wall St.
Jul-16-16 11:20AM  3 Tech Stocks You Should Buy Right Now at Motley Fool
09:05AM  UBS Says Buy Quality: 4 Stocks With Big Upside to Their Price Targets at 24/7 Wall St.
Jul-15-16 07:44PM  StubHub Just Bought a Ticket Software Company at Fortune
04:16PM  Value picks for this rally
09:30AM  Zacks Industry Outlook Highlights: Facebook, Twitter, Amazon, eBay and Alibaba
01:01AM  [$$] Campaign Wire at The Wall Street Journal
12:47AM  [$$] Campaign Wire at The Wall Street Journal
Jul-14-16 04:38PM  Better Buy: eBay Inc. vs. Overstock.com at Motley Fool
04:21PM  Is Ebay Now A Better Buy Than PayPal?
04:14PM  Over 100 tech execs sign an open letter declaring that they are against Trump at CNBC
03:25PM  Dow, S&P 500 Near Highs Heading Into Close; Line IPO Soars In Debut
12:54PM  Earnings Preview: eBay Inc. Q2 2016 (EBAY)
11:14AM  Heres Why Googles Antitrust Defense Is Faltering in Europe at Fortune
11:04AM  What Are Analysts Recommendations for AMZN, BABA, and EBAY?
08:34AM  Here's Why eBay Is Acquiring SalesPredict? at Forbes
Jul-13-16 06:49PM  Winmark Corp & the Evolving Retail Industry
eBay Inc. operates e-commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer inventory for sale; and buyers to find and buy it virtually anytime and anywhere. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com and the StubHub mobile apps, which enable fans to purchase tickets to the games, concerts, and theater shows. Its Classifieds platforms include a collection of brands, such as Mobile.de, Kijiji, Gumtree, Marktplaats, eBay Classifieds, and others that offer online classifieds and help people find whatever they are looking for in their local communities. The company platforms enable users to find, buy, sell, and pay for items through various online, mobile, and offline channels, which include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. was founded in 1995 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schenkel Scott F.SVP, Chief Financial OfficerJul 17Option Exercise0.001,768092,875Jul 18 08:27 PM
WENIG DEVINPresident and CEOJul 17Option Exercise0.005,8950449,754Jul 18 07:55 PM
Lawton III Harry ASVP, N.A.Jun 15Option Exercise0.0042,723039,075Jun 17 07:57 PM
Lee Jae HyunSVP, Asia PacificJun 15Option Exercise0.003,1270122,144Jun 17 07:53 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerJun 15Option Exercise0.005,732029,461Jun 17 07:50 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 15Option Exercise0.004,559037,376Jun 17 07:46 PM
Todd Jeremy PaulSVP, EMEAJun 15Option Exercise0.0014,501057,098Jun 17 07:42 PM
WENIG DEVINPresident and CEOJun 15Option Exercise0.0013,0870450,688Jun 17 08:18 PM
Schenkel Scott F.SVP, Chief Financial OfficerJun 15Option Exercise0.006,253094,370Jun 17 08:15 PM
Huber Marie OhSVP, GC & SecretaryJun 15Option Exercise0.0031,556029,055Jun 17 08:10 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0015,543041,926Jun 17 08:04 PM
FISHER STEPHENSVP, CTOJun 15Option Exercise0.007,295079,149Jun 16 08:42 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 08Option Exercise0.0011,388038,760Jun 09 05:22 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 27Sale24.2425,000605,89823,729Jun 01 04:28 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Option Exercise16.6814,474241,42641,846May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Sale24.0814,474348,53427,372May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Option Exercise16.6820,000333,60047,372May 10 07:49 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Sale24.0320,000480,65027,372May 10 07:49 PM
Yetto Kristin ASVP, Chief People OfficerApr 29Sale24.1110,630256,30428,343May 03 07:29 PM
Yetto Kristin ASVP, Chief People OfficerApr 01Option Exercise0.0027,861052,553Apr 05 08:01 PM
WENIG DEVINPresident and CEOApr 01Option Exercise0.0078,0130477,120Apr 05 07:59 PM
Todd Jeremy PaulSVP, EMEAApr 01Option Exercise0.0017,168052,659Apr 05 07:49 PM
Schenkel Scott F.SVP, Chief Financial OfficerApr 01Option Exercise0.0025,0330100,013Apr 05 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerApr 01Option Exercise0.0010,973053,026Apr 05 07:47 PM
Lee Jae HyunSVP, Asia PacificApr 01Option Exercise0.0016,1830117,850Apr 05 07:36 PM
FISHER STEPHENSVP, CTOApr 01Option Exercise0.0010,919077,552Apr 05 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerApr 01Option Exercise0.0025,327036,892Apr 05 07:33 PM
PITTMAN RAYMOND JSVP, Chief Product Officer,Feb 26Option Exercise20.9428,204590,592111,323Mar 01 06:53 PM
PITTMAN RAYMOND JSVP, Chief Product Officer,Feb 26Sale24.3378,5371,910,77232,786Mar 01 06:53 PM
TIERNEY THOMAS JDirectorFeb 17Option Exercise6.694,42429,59719,901Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 17Sale23.084,424102,10615,477Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 16Option Exercise6.693,57623,92319,053Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 16Sale23.003,57682,24815,477Feb 18 07:01 PM
PRESSLER PAUL SDirectorFeb 01Buy23.944,180100,05410,448Mar 04 08:16 PM
SWAN ROBERT HOLMESDirectorFeb 01Sale23.7450,0001,187,065474,469Feb 03 05:23 PM
Doerger Brian J.VP, Chief Accounting OfficerDec 15Option Exercise0.0013,928018,833Dec 17 07:02 PM
PITTMAN RAYMOND JSVP, Chief Product Officer, MaDec 15Option Exercise0.00131,9130149,518Dec 17 06:42 PM
PRESSLER PAUL SDirectorNov 30Buy29.125,140149,6905,140Dec 01 04:57 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaNov 30Sale29.2520,000585,00088,534Dec 02 06:27 PM
ANDERSON FRED DDirectorNov 09Option Exercise9.853,50334,50517,480Nov 12 06:24 PM
ANDERSON FRED DDirectorNov 09Sale29.003,503101,58713,977Nov 12 06:24 PM
Yetto Kristin ASVP, Human ResourcesNov 05Sale29.136,638193,36614,025Nov 09 05:29 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaNov 03Option Exercise14.867,677114,080136,211Nov 05 05:41 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaNov 03Sale28.8827,677799,389108,534Nov 05 05:41 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerOct 30Sale27.9821,000587,58017,605Nov 03 06:48 PM
FISHER STEPHENSVP & Chief Technology OfficerOct 26Option Exercise21.2038,714820,72393,826Oct 27 09:15 PM
FISHER STEPHENSVP & Chief Technology OfficerOct 26Sale27.9078,7752,197,44715,051Oct 27 09:15 PM
FISHER STEPHENSVP & Chief Technology OfficerOct 15Option Exercise0.00106,5510106,551Oct 19 05:45 PM
Schenkel Scott F.SVP and CFOOct 15Option Exercise0.005,907039,341Oct 16 07:34 PM
WENIG DEVINPresident and CEOOct 15Option Exercise0.0013,8980312,322Oct 16 08:02 PM
WENIG DEVINPresident and CEOOct 14Option Exercise0.00151,7080377,586Oct 16 08:02 PM
Schenkel Scott F.SVP and CFOOct 14Option Exercise0.0059,459064,460Oct 16 07:34 PM
Doerger Brian J.VP, Chief Accounting OfficerAug 28Sale27.074,658126,1014,905Sep 01 08:13 PM
Todd Jeremy PaulSVP, EuropeAug 10Option Exercise0.0032,936035,491Aug 12 05:47 PM
SWAN ROBERT HOLMESDirectorJul 31Option Exercise10.23494,6345,058,299578,028Aug 04 06:07 PM
SWAN ROBERT HOLMESDirectorJul 31Sale28.30494,63414,000,41883,394Aug 04 06:07 PM
SWAN ROBERT HOLMESDirectorJul 27Sale27.9538,5221,076,825523,633Jul 29 07:46 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E23.48 EPS (ttm)1.26 Insider Own0.30% Shs Outstand2.07B Perf Week0.48%
Market Cap61.18B Forward P/E20.07 EPS next Y1.47 Insider Trans0.40% Shs Float1.41B Perf Month2.71%
Income2.54B PEG3.78 EPS next Q0.31 Inst Own34.20% Short Float0.55% Perf Quarter8.13%
Sales24.56B P/S2.49 EPS this Y-14.40% Inst Trans0.01% Short Ratio1.87 Perf Half Y36.79%
Book/sh10.39 P/B2.84 EPS next Y8.16% ROA5.20% Target Price32.42 Perf Year7.70%
Cash/sh0.08 P/C380.92 EPS next 5Y6.22% ROE12.40% 52W Range19.00 - 30.10 Perf YTD15.40%
Dividend1.60 P/FCF- EPS past 5Y16.90% ROI8.30% 52W High-1.93% Beta0.83
Dividend %5.42% Quick Ratio0.60 Sales past 5Y-4.30% Gross Margin13.70% 52W Low55.37% ATR0.63
Employees6800 Current Ratio0.80 Sales Q/Q-33.00% Oper. Margin14.50% RSI (14)58.92 Volatility1.77% 2.14%
OptionableYes Debt/Eq1.08 EPS Q/Q0.00% Profit Margin10.30% Rel Volume0.73 Prev Close29.39
ShortableYes LT Debt/Eq1.04 EarningsJul 28 BMO Payout121.90% Avg Volume4.17M Price29.52
Recom1.70 SMA201.33% SMA504.40% SMA20015.11% Volume3,046,400 Change0.44%
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
May-02-14Reiterated Oppenheimer Outperform $74 → $86
Mar-20-14Reiterated Stifel Buy $70 → $75
Jan-31-14Reiterated Argus Buy $70 → $75
Jan-06-14Reiterated Deutsche Bank Buy $70 → $74
Aug-02-13Resumed Oppenheimer Outperform $67 → $71
Aug-02-13Reiterated Stifel Buy $64 → $68
Jul-24-16 02:13PM  [$$] Landscape shifts for pipeline operators at Financial Times
12:00PM  3 Dividend Stocks You Don't Have to Babysit at Motley Fool
Jul-23-16 01:06PM  3 Stocks That Retirees Should Consider Buying Today at Motley Fool
Jul-22-16 01:12PM  How Are Analysts Rating EPD Ahead of Its 2Q16 Earnings Release?
01:12PM  Will Enterprise Products Partners Benefit from the Global Oil Supply?
01:12PM  What Will Fuel Enterprise Products Partners Growth Going Forward?
01:12PM  Inside Enterprise Products Key Strategy
Jul-20-16 04:08PM  Why Are the Gathering and Processing Businesses Pressuring Enterprise Products?
04:08PM  How Are EPDs Segments Expected to Perform in 2Q16?
04:08PM  Enterprise Products Is Expected to Report Higher 2Q16 Earnings
12:28PM  These 3 Stocks Just Raised Their Dividends at Motley Fool
Jul-19-16 04:56PM  After 4-Month Run-Up, Are MLPs Still Cheap? at Barrons.com
03:51PM  Bahnsen: Enterprise Products is the cream of the crop nam...
08:30AM  Enterprise Adds Propylene Exports to Service Offerings at Houston Ship Channel Facility Business Wire
Jul-17-16 10:05AM  More Upgraded Expectations for Kinder Morgan and Enterprise at 24/7 Wall St.
Jul-16-16 09:50AM  Oil Rig Count Up by 6 Last Week, Hedge Funds Turn Long on Crude, Distillates at 24/7 Wall St.
09:35AM  3 Stocks to Buy With Dividends Yielding More Than 5% at Motley Fool
Jul-15-16 09:05AM  Why 43% of Analysts Rate Kinder Morgan Buy before 2Q16 Results
Jul-14-16 10:33AM  7 Dividend Hikes In 7 Days
Jul-13-16 02:04PM  1 Stock to Own in Energy at Motley Fool
09:53AM  PAA Aims to Lower Cost of Capital and Improve Coverage
Jul-12-16 06:19PM  Firms scrap July US LPG cargo loadings due to low spot prices -sources Reuters
03:28PM  Kinder Morgan Is Expected to Report Lower 2Q16 Earnings
12:00PM  5 Top Pipeline Stocks to Buy in 2016 at Motley Fool
10:08AM  Pioneer Paid Final Settlement by Enterprise Products Partners
08:05AM  3 Dividend Stocks That Prove Boring Is Beautiful at Motley Fool
Jul-11-16 10:15AM  Enterprise Makes Final Payment for EFS Midstream Assets Business Wire
09:50AM  RBC Sees MLPs in a New Trading Range: 4 Top Picks Now at 24/7 Wall St.
Jul-09-16 09:35AM  Oil Rig Count Up by 10 Last Week, Hedge Funds Add to Short Positions at 24/7 Wall St.
Jul-08-16 12:20PM  Are Kinder Morgan Shares a Value Play? at 24/7 Wall St.
09:46AM  Enterprise Products Partners Raises Quarterly Distribution
Jul-07-16 02:56PM  Enterprise Hikes Dividend by 5.3%, Provides 5.4% Yield
10:05AM  Enterprise Keeps Defying Outside MLP Gravity with Yet Another Distribution Hike at 24/7 Wall St.
09:27AM  Enterprise Declares Quarterly Distribution Increase Business Wire
Jul-06-16 02:31PM  US oil reserves surge
10:25AM  MLP Index Has First Positive Quarter Since 2014: 4 Top Stocks to Buy at 24/7 Wall St.
Jul-05-16 11:53AM  Analyzing US Crude Oil Movement by Rail in April 2016
Jul-04-16 02:06PM  US Crude-by-Rail Movements Keep Falling: MLP Impact
Jul-03-16 11:08AM  2 Stocks to Buy With Dividends Yielding More Than 5% at Motley Fool
Jul-02-16 09:33AM  Oil Rig Count Jumped by 11 Last Week, Hedge Funds Changed Directions Again at 24/7 Wall St.
Jun-29-16 03:30PM  Houston family registers on richest list at bizjournals.com
12:36PM  Enterprise Sees Plant Curbing Gulf Oil, Gas Supply Down for Days at Bloomberg
11:36AM  Mississippi Plant Blast Hampers Gulf Production
11:06AM  Enterprise's Pascagoula Plant Catches Fire, Closed for Now
Jun-28-16 01:35PM  Returns for Midstream Stocks with High and Low Implied Volatility
12:40PM  Enterprise Pascagoula Natural Gas Processing Plant Experiences Fire Business Wire
12:10PM  LLOG in process of shutting Delta House system in Gulf of Mexico
11:32AM  Enterprise Gas Plant Blast Curbs Gulf of Mexico Oil, Gas Supply at Bloomberg
09:19AM  Why EQT Midstream Looks Good amid Global Uncertainties
07:29AM  The Latest: Police: Mississippi plant blasts, no injuries
Jun-27-16 09:04AM  Targa Resources Trades at a Higher Forward Yield than Peers
09:04AM  What Does Targa Resources Current Valuation Indicate?
Jun-26-16 11:20AM  Keep the IRS at Bay With These 2 Tax-Slashing Investment Moves
Jun-25-16 08:52AM  Oil Rig Count Fell by 7 Last Week, Hedge Funds Bet Wrong on Brexit at 24/7 Wall St.
Jun-23-16 03:01PM  [$$] MLPs Set for a Pricing Boost at Barrons.com
Jun-22-16 09:40AM  5 Can't Miss Quotes from Enterprise Products Partners' Management Team at Motley Fool
Jun-21-16 09:39AM  Enterprise (EPD) to Build Third Cryogenic Plant in Delaware
Jun-20-16 04:14PM  Enterprise Is the Latest to Bet on Mexicos Thirst for U.S. Gas at Bloomberg
04:00PM  Natural gas giant to build another plant, pipelines at bizjournals.com
08:30AM  Enterprise to Further Expand Delaware Basin Network with New Natural Gas Processing Plant Business Wire
06:30AM  Enterprise Products Partners to Participate in Investor Conferences Business Wire
Jun-18-16 09:35AM  Oil Rig Count Rose by 9 Last Week, Hedge Funds Pile Up Short Contracts at 24/7 Wall St.
Jun-12-16 10:00AM  These 3 Oil Stocks Could Boost Their Dividends in 2016 at Motley Fool
Jun-11-16 09:35AM  Oil Rig Count Rose by 3 Last Week, Some Hedge Funds Going Very Long at 24/7 Wall St.
Jun-09-16 04:46PM  3 Stocks We're Never Selling at Motley Fool
Jun-07-16 01:03PM  3 High-Yield Oil Stocks With Increasing Dividends
09:19AM  Research Report Initiated on Select Independent Oil and Gas Equities
Jun-06-16 12:44PM  BASF postpones Texas chemical plant on 'volatile' commodity prices
Jun-04-16 09:40AM  Oil Rig Count Jumped by 9 Last Week, Hedge Funds Cant Decide Direction at 24/7 Wall St.
Jun-02-16 01:45PM  Alerian MLP Index Turns 10, Returns Averaged 8.8% a Year at Barrons.com
12:21PM  Thummel: OPEC is becoming less relevant
Jun-01-16 06:03AM  Returns of Midstream Stocks with High and Low Implied Volatility
May-31-16 05:07PM  How ONEOK Partners Performed So Strongly in Challenging Times
05:07PM  ONEOK Partners Leverage: Key for Investors
08:00AM  Enterprise Products Partners to Present at MLPA Investor Conference Business Wire
May-30-16 03:00PM  How Last Weeks Ethane Prices Impacted MLPs
May-29-16 08:34AM  1 Stock I'd Never Put in an IRA at Motley Fool
May-28-16 10:00AM  3 Investing Tips for MLPs That Could Earn You Thousands at Motley Fool
09:10AM  Oil Rig Count Dropped by 2 Last Week, Hedge Funds Take a Breather at 24/7 Wall St.
May-26-16 10:50AM  Energy MLPs Up 50% From Lows: 4 That Remain Top Analyst Picks at 24/7 Wall St.
09:05AM  5 High-Yield Dividend Stocks You Definitely Want to Consider at Motley Fool
May-21-16 09:35AM  Oil Rig Count Flat Last Week, Hedge Funds Dump Short Bets at 24/7 Wall St.
May-20-16 08:33AM  3 Top Stocks for Low-Risk Investors at Motley Fool
May-17-16 10:05AM  Investors Very Interested in These 3 Quality MLPs as Oil Prices Push Higher at 24/7 Wall St.
May-16-16 08:50AM  5 Rocket Stocks That Could Blast Off Soon at TheStreet
May-15-16 09:35AM  7 Oil and Gas Stocks Analysts Want You to Buy at 24/7 Wall St.
May-14-16 04:13PM  Energy-Focused Wexford Capital Reveals Top Stock Picks Dominated by MLPs at Insider Monkey
09:35AM  Oil Rig Count Drops by 10, Hedge Funds Raise Short Bets at 24/7 Wall St.
May-12-16 04:23PM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Change in Directors or Principal Officers
01:04PM  ENTERPRISE PRODUCTS PARTNERS L P Financials
May-11-16 03:56PM  Bernstein Wants Clients Buying Several Top MLPs at 24/7 Wall St.
06:59AM  Coverage initiated on Enterprise Products by Bernstein
May-09-16 08:20AM  3 Quality MLPs to Buy With Safe Distributions of 6% or More
07:00AM  Enterprise Products Partners to Participate in Investor Conferences Business Wire
May-07-16 10:06AM  3 Oil and Gas Stocks You Don't Have to Babysit at Motley Fool
09:35AM  Oil Rig Count Drops by 5, Hedge Funds Grow Wary on Crude at 24/7 Wall St.
08:00AM  3 Top Stocks for Low-Risk Investors at Motley Fool
May-06-16 11:39AM  Time To Dip Into MLPs Again? 3 To Watch And 2 To Sell at Forbes
11:33AM  Whats Driving Williams Partners Market Performance? Market Realist
06:05AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-Q, Quarterly Report EDGAR Online
Enterprise Products Partners L.P., a master limited partnership, provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,500 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas export terminal and NGL import facility. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 478 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,100 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 674 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines of approximately 4,200 miles; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARTH CARIN MARCYDirectorFeb 12Buy20.525,000102,6005,000Feb 17 04:06 PM
MCMAHEN CHARLES EDirectorFeb 12Buy19.9910,000199,90097,554Feb 12 04:13 PM
Montgomery William CDirectorFeb 11Buy19.6910,000196,90036,500Feb 11 06:48 PM
WILLIAMS RANDA DUNCANDirectorJan 04Buy26.113,830,256100,007,9843,330,619Jan 04 05:47 PM
ANDRESS THURMONDirectorDec 22Buy25.102,50062,74247,552Dec 22 06:20 PM
TEAGUE AJChief Operating OfficerDec 07Buy21.307,040149,952469,493Dec 07 04:26 PM
TEAGUE AJChief Operating OfficerDec 07Buy21.2923,475499,7831,389,300Dec 07 04:26 PM
Montgomery William CDirectorDec 07Buy21.2510,000212,50026,500Dec 07 04:15 PM
FOWLER W RANDALLChief Administrative OfficerDec 07Buy21.515,000107,550741,083Dec 07 04:08 PM
HACKETT JAMES TDirectorDec 02Buy24.5025,000612,50025,000Dec 02 04:10 PM
HACKETT JAMES TDirectorDec 02Buy24.50100,0002,450,000216,497Dec 02 04:10 PM
Bulawa Bryan F.SVP & Chief Financial OfficerNov 16Option Exercise16.1410,000161,350125,574Nov 17 04:34 PM
TEAGUE AJChief Operating OfficerSep 28Buy23.466,400150,1441,364,581Sep 29 04:27 PM
Bulawa Bryan F.SVP & Chief Financial OfficerAug 17Option Exercise16.1420,000322,700130,291Aug 19 04:15 PM
KNESEK MICHAEL JSVP, PAO, & ControllerAug 06Buy26.251674,384167Aug 06 04:03 PM
Bulawa Bryan F.SVP & Chief Financial OfficerAug 03Buy27.301,00027,300110,291Aug 03 04:18 PM
HACKETT JAMES TDirectorAug 03Buy27.72100,0002,772,000116,497Aug 03 04:46 PM
TEAGUE AJChief Operating OfficerAug 03Buy28.0712,600353,667462,453Aug 03 04:20 PM
TEAGUE AJChief Operating OfficerAug 03Buy27.673,32591,9991,356,895Aug 03 04:20 PM
TEAGUE AJChief Operating OfficerJul 31Buy28.7020,000573,9481,353,570Aug 03 04:20 PM
Cardillo Gerald R.Group Senior Vice PresidentJul 31Buy28.5560017,130176,174Aug 03 04:16 PM
FOWLER W RANDALLChief Administrative OfficerJul 31Buy28.473,00085,406736,083Aug 03 04:14 PM
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-2.14 Insider Own2.30% Shs Outstand366.02M Perf Week-0.17%
Market Cap8.35B Forward P/E2.88 EPS next Y7.93 Insider Trans2.51% Shs Float332.75M Perf Month5.45%
Income-739.10M PEG- EPS next Q1.56 Inst Own66.80% Short Float9.09% Perf Quarter-36.58%
Sales10.63B P/S0.79 EPS this Y-133.00% Inst Trans19.01% Short Ratio0.97 Perf Half Y-74.24%
Book/sh16.40 P/B1.39 EPS next Y20.32% ROA-1.50% Target Price42.72 Perf Year-91.01%
Cash/sh3.58 P/C6.37 EPS next 5Y7.70% ROE-12.10% 52W Range18.55 - 263.81 Perf YTD-77.55%
Dividend- P/FCF4.16 EPS past 5Y4.40% ROI3.70% 52W High-91.35% Beta0.31
Dividend %- Quick Ratio1.10 Sales past 5Y54.60% Gross Margin75.20% 52W Low23.02% ATR1.38
Employees22000 Current Ratio1.40 Sales Q/Q9.30% Oper. Margin9.90% RSI (14)48.73 Volatility5.15% 6.43%
OptionableYes Debt/Eq5.65 EPS Q/Q-480.80% Profit Margin-7.00% Rel Volume0.76 Prev Close24.48
ShortableYes LT Debt/Eq5.54 EarningsAug 09 BMO Payout- Avg Volume31.12M Price22.82
Recom3.00 SMA203.32% SMA50-6.23% SMA200-65.74% Volume23,420,300 Change-6.78%
Jun-23-16Downgrade JP Morgan Overweight → Neutral
Jun-08-16Reiterated Stifel Buy $65 → $55
Jun-08-16Reiterated RBC Capital Mkts Sector Perform $58 → $33
Jun-08-16Reiterated Mizuho Underperform $18 → $11
May-03-16Reiterated Rodman & Renshaw Buy $105 → $102
Apr-12-16Reiterated RBC Capital Mkts Sector Perform $69 → $65
Apr-11-16Reiterated Rodman & Renshaw Buy $118 → $105
Mar-21-16Downgrade Mizuho Neutral → Underperform $70 → $18
Mar-21-16Downgrade Barclays Overweight → Equal Weight $135 → $34
Mar-16-16Reiterated Stifel Buy $200 → $65
Mar-16-16Reiterated Rodman & Renshaw Buy $150 → $118
Mar-16-16Reiterated RBC Capital Mkts Sector Perform $85 → $69
Mar-16-16Reiterated Canaccord Genuity Hold $75 → $40
Mar-16-16Downgrade Nomura Buy → Neutral $175 → $60
Mar-16-16Downgrade CIBC Sector Perform → Sector Underperform
Mar-15-16Downgrade Piper Jaffray Neutral → Underweight
Mar-08-16Reiterated Mizuho Neutral $112 → $70
Mar-02-16Downgrade Canaccord Genuity Buy → Hold $125 → $75
Mar-01-16Downgrade RBC Capital Mkts Outperform → Sector Perform $194 → $85
Feb-29-16Downgrade TD Securities Buy → Hold
Jul-24-16 06:41PM  Ackman's Bad Bets Costs $600 Million in Redemptions at Investopedia
Jul-23-16 12:18AM  [$$] Valeant: Not All Delays Are Created Equal at The Wall Street Journal
Jul-22-16 08:29PM  [$$] Overheard at The Wall Street Journal -6.78%
04:40PM  CANADA STOCKS-TSX at highest close in year, 4th weekly gain; telecoms shine
02:16PM  Deficiencies at Bausch + Lomb manufacturing plant in Tampa put glaucoma drug on hold at bizjournals.com
12:15PM  Valeant Hits Another Bump
12:11PM  Valeant Slides as FDA Report Hampers Drug Application at TheStreet
11:48AM  Valeant just got blindsided
11:35AM  Valeants latest woe isnt even financial at MarketWatch
11:28AM  Valeant Pharmaceuticals: It Had to End Some Time at Barrons.com
10:34AM  Valeant: Not All Delays Are Created Equal at The Wall Street Journal
10:02AM  Valeant (VRX) Stock Down on Concerns About Glaucoma Treatment
08:44AM  Morning Movers: General Electric Falls on Earnings; Valeant Drops at Barrons.com
07:58AM  Valeant Drug Approval Hampered by FDA Facility Inspection
03:36AM  U.S. FDA raises concerns over Valeant's eye drop Reuters
02:00AM  Valeant Pharmaceuticals Receives Complete Response Letter From The FDA PR Newswire
02:00AM  Valeant Pharmaceuticals Receives Complete Response Letter From The FDA CNW Group
Jul-21-16 04:42PM  3 Cheap Healthcare Stocks You Can Buy Right Now at Motley Fool
03:53PM  BBP: An Outperforming Biotechnology ETF
10:39AM  Valeant & Endo: Imagining a World With No Drug Pricing Controversies at Barrons.com
08:09AM  Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : July 21, 2016
Jul-20-16 04:12PM  Why Progenics Pharmaceuticals, Inc. Shares Soared Today at Motley Fool
03:59PM  Valeant Scores a Rare Win: Have They Turned a Corner?
03:50PM  Why Valeant, Progenics, Ryerson, Zafgen and TerraForm Are On The Move Today at Insider Monkey
03:25PM  A tiny clarification on the most positive thing Bill Ackman said during his conference call
03:06PM  These 3 Stocks Are Rising on Big Volume -- Is It Time to Buy?
01:51PM  Ackman Defends Valeants Drug Development on Investor Call at Bloomberg
01:50PM  Valeant gets new approval for legacy Salix drug at bizjournals.com
01:44PM  Here's Why Jim Cramer Is Positive About Valeant Pharmaceuticals at TheStreet
12:38PM  Pershing Square: An Update on Herbalife and Second Quarter Results at The Wall Street Journal
12:30PM  Valeant's Drug Approvals May Save the Day
12:29PM  Wait, Did Valeant Do Something Right? at Bloomberg
11:47AM  Valeant: Can New Drug Launches Drive Growth?
11:43AM  Can Valeant Pharmaceuticals Intl Inc (VRX) Hit Three For Three Tomorrow? at Insider Monkey
10:41AM  Stocks Move Higher as Crude Oil Pares Losses
10:22AM  Valeant Pharmaceuticals: Two for Two at Barrons.com
10:19AM  Jim Cramer -- Valeant Needs These New Drug Approvals
10:07AM  Valeant (VRX) Stock Gains as FDA Approves Anticonstipation Drug
10:05AM  Could This Be the Turning Point for Progenics and Valeant? at 24/7 Wall St.
09:40AM  Stocks Open Higher; Intuitive Surgical, Microsoft Kick Up
09:36AM  Stocks to Watch: Microsoft, Progenics, Valeant, Morgan Stanley, Zafgen, Halliburton at The Wall Street Journal
09:34AM  Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
09:23AM  Here's the Most Overrated Investing Metric You'll Ever See at Motley Fool
09:21AM  Valeant Scores 'Vindicating Win' as 2 Key Drugs Clear FDA Hurdles
09:10AM  Could Fiat Chrysler Become the Valeant of the Auto Industry? at 24/7 Wall St.
08:26AM  Morning Movers: Morgan Stanley Jumps on Earnings; Valeant Pharmaceuticals Climbs on Drug Approval at Barrons.com
08:13AM  Morning Movers: MS, VRX, MSFT, ISRG
Jul-19-16 11:04PM  Futures Point Downward for U.S. Markets as Asia Opens Lower
08:32PM  Valeant Gets FDA OK for Anticonstipation Tablets Developed by Progenics at The Wall Street Journal
06:50PM  Investors Pull $600M After Ackmans Bad Bets at Fortune
06:25PM  Valeant, Progenics shares rise on constipation drug approval at MarketWatch
06:04PM  Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain PR Newswire
06:04PM  Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain CNW Group
05:27PM  [$$] Valeant Gets FDA Panel Recommendation for Psoriasis Drug at The Wall Street Journal
04:53PM  Valeant gets FDA panel recommendation for psoriasis drug at MarketWatch
04:27PM  FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis PR Newswire
04:27PM  FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis CNW Group
04:22PM  U.S. FDA panel backs Valeant psoriasis drug with risk program Reuters
04:21PM  New Valeant (VRX) Drug Gains Approval From FDA Panel
03:45PM  Valeant Drug Should Be Approved With Risk Plan, FDA Advisers Say at Bloomberg
03:40PM  Valeant (VRX) Stock Higher, FDA Panel Backs Psoriasis Drug
03:25PM  U.S. FDA panel backs Valeant psoriasis drug with risk management Reuters
02:24PM  Whats Next for Valeant after Its Former CEO Sold His Holdings?
02:24PM  Inside Bill Ackmans Current Stance and View of His Holdings
01:21PM  ETFs with exposure to Valeant Pharmaceuticals International, Inc. : July 19, 2016
09:37AM  Bill Ackman's Assault on Herbalife Fizzles at Investopedia
Jul-18-16 06:49PM  Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
04:53PM  Valeant Stock Surges Ahead of Anticipated Drug Approval at TheStreet
04:30PM  Valeant Partnership With Walgreens in Trouble: Andrew Left
02:30PM  Valeant-Walgreens Partnership Destined to Flop, Andrew Left Says
01:15PM  Learn from Bill Ackman's Mistakes
12:58PM  Outperform With A Crowded Positions Strategy
12:27PM  Valeant (VRX) Stock Higher Ahead of Anticipated FDA Approval
01:00AM  Pharming Announces Positive Results from Randomized Controlled Trial with RUCONEST® for HAE Prophylaxis PR Newswire
Jul-16-16 01:15PM  Bad year for Wall Street's Golden Boy Ackman AFP
11:41AM  3 Primary Ways Researchers Are Combatting Cancer at Motley Fool
Jul-15-16 09:28PM  U.S. Retail Sales Did Better Than Expected in June; the Nikkei 225 Had a Great Week: Best of Kass
05:41PM  Bill Ackman Just Can't Seem to Catch a Break With Regulators
05:02PM  Bill Ackmans annus horribilis is only getting worse at MarketWatch
04:45PM  Bill Ackman's Herbalife Settles with FTC, Stock Is Undervalued
03:39PM  Valeant Pharmaceuticals' Second-Largest Shareholder Just Abandoned Ship -- Should You, Too? at Motley Fool
01:49PM  Better Buy: Valeant Pharmaceuticals International, Inc. vs. Ionis Pharmaceuticals, Inc. at Motley Fool
12:46PM  Trending Tickers: CBS, VRX, CMG, CTSH
11:29AM  Ackman Again Whipsawed by Herbalife, Valeant as Regulators Disappoint Pershing
11:05AM  Herbalife Spikes On FTC Settlement, Will Fix Rewards Structre
10:52AM  Valeant: Why Long-Term Investors are Pulling Out?
10:25AM  2 Forgotten Activists In Herbalife: David Einhorn And Dan Loeb
09:44AM  Valeant (VRX) Stock Falls on FDA Scrutiny
09:00AM  FDA Staff Split Over Suicide Risk of Valeants Psoriasis Drug at Bloomberg
08:26AM  Valeant psoriasis drug safety challenging to assess -FDA Staff Reuters
08:00AM  Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details PR Newswire
08:00AM  Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details CNW Group
06:58AM  Valeants stock chart warns not to board the bearish bandwagon at MarketWatch
Jul-14-16 06:34PM  Why Cree, Harsco, and Valeant Pharmaceuticals Jumped Today at Motley Fool +6.48%
04:24PM  Valeant (VRX) Stock Closed Higher Today After CEO Statement
03:20PM  Jim Cramer: I'm Watching Valeant and Its Debt Load at TheStreet
01:59PM  Valeant Has Split the Analyst Community
01:10PM  Bill Ackman threw serious shade at the short seller who tanked Valeant
01:00PM  Ackman says Valeant has no current plans to sell core assets at CNBC
12:53PM  Turns out nobody ever really wanted Bill Ackman at Valeant
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ross Thomas W. Sr.DirectorJun 13Buy24.404,00097,60021,882Jun 27 03:40 PM
PAPA JOSEPH CCHAIRMAN & CEOJun 10Buy24.48202,0004,944,9602,442,199Jun 13 06:47 AM
Pearson J. MichaelChief Executive OfficerNov 05Sale78.481,297,399101,825,9701,514,664Nov 09 05:24 PM
Farmer Ronald HaroldDirectorOct 21Buy181.601,500272,39515,532Oct 22 05:09 PM
Farmer Ronald HaroldDirectorAug 26Buy220.00500110,0002,000Aug 27 04:33 PM
Farmer Ronald HaroldDirectorAug 21Buy224.971,000224,9731,500Aug 25 04:47 PM
Rosiello Robert L.EVP, Chief Financial OfficerJul 31Buy257.25704181,104441,675Aug 03 04:54 PM
Rosiello Robert L.EVP, Chief Financial OfficerJul 30Buy253.997,1711,821,362440,971Aug 03 04:54 PM
LYB LyondellBasell Industries N.V. daily Stock Chart
LYB [NYSE]
LyondellBasell Industries N.V.
IndexS&P 500 P/E8.26 EPS (ttm)9.47 Insider Own0.10% Shs Outstand431.81M Perf Week0.32%
Market Cap33.75B Forward P/E7.96 EPS next Y9.82 Insider Trans-83.02% Shs Float347.63M Perf Month-1.03%
Income4.34B PEG1.27 EPS next Q2.53 Inst Own76.20% Short Float2.82% Perf Quarter-12.43%
Sales31.29B P/S1.08 EPS this Y20.00% Inst Trans0.08% Short Ratio2.95 Perf Half Y1.65%
Book/sh14.65 P/B5.34 EPS next Y0.89% ROA18.30% Target Price89.67 Perf Year-13.43%
Cash/sh6.14 P/C12.74 EPS next 5Y6.50% ROE61.60% 52W Range67.69 - 95.46 Perf YTD-8.19%
Dividend3.40 P/FCF12.98 EPS past 5Y-11.60% ROI30.00% 52W High-18.12% Beta1.80
Dividend %4.35% Quick Ratio1.40 Sales past 5Y-4.50% Gross Margin21.90% 52W Low15.46% ATR1.87
Employees13000 Current Ratio2.30 Sales Q/Q-17.60% Oper. Margin19.10% RSI (14)52.69 Volatility1.74% 2.39%
OptionableYes Debt/Eq1.43 EPS Q/Q-2.10% Profit Margin13.90% Rel Volume0.93 Prev Close79.09
ShortableYes LT Debt/Eq1.34 EarningsJul 29 BMO Payout32.90% Avg Volume3.32M Price78.16
Recom2.60 SMA202.88% SMA50-0.75% SMA200-5.99% Volume3,108,600 Change-1.18%
Jun-27-16Downgrade RBC Capital Mkts Outperform → Sector Perform $100 → $84
Jun-23-16Downgrade JP Morgan Overweight → Neutral $100 → $80
Jun-13-16Downgrade Cowen Outperform → Market Perform $105 → $87
Apr-27-16Downgrade Nomura Buy → Neutral
Apr-05-16Downgrade Atlantic Equities Neutral → Underweight
Feb-03-16Downgrade RBC Capital Mkts Top Pick → Outperform $105 → $95
Jan-11-16Downgrade Credit Agricole Outperform → Underperform
Nov-25-15Reiterated Cowen Outperform $98 → $105
Oct-12-15Downgrade Macquarie Outperform → Neutral
Sep-17-15Reiterated Deutsche Bank Hold $100 → $95
Sep-11-15Initiated Bernstein Outperform $110
Sep-01-15Reiterated Cowen Outperform $115 → $98
May-08-15Initiated Standpoint Research Buy
Apr-28-15Reiterated RBC Capital Mkts Top Pick $111 → $123
Apr-27-15Reiterated Jefferies Hold $85 → $99
Apr-27-15Reiterated Deutsche Bank Hold $96 → $105
Apr-27-15Reiterated Barclays Overweight $105 → $115
Mar-13-15Initiated Argus Hold
Feb-13-15Downgrade Deutsche Bank Buy → Hold $96
Feb-04-15Reiterated RBC Capital Mkts Top Pick $102 → $105
Jul-25-16 04:12AM  Dividend Investors Should Research These 10 Stocks - July
Jul-24-16 10:45PM  Why Analysts Are Expecting Lower Revenue for LyondellBasell in 2Q16
Jul-22-16 07:55PM  Why Has the JPMorgan Large-Cap Growth Fund Done so Poorly in 2016?
09:00AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Jul-21-16 08:11AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : July 21, 2016
Jul-19-16 04:50PM  [video]3 Prudent Stocks to Own in a Frothy Market
03:59PM  What Are Analysts Predicting for Dow Chemical Revenue in 2Q16?
03:51PM  Bahnsen: Enterprise Products is the cream of the crop nam...
Jul-15-16 08:15AM  LyondellBasell to Discuss Second-Quarter Results on Friday, July 29, 2016 PR Newswire
02:18AM  LyondellBasell Selects WorleyParsons for PO/TBA Plant Integrated Project Management Business Wire
Jul-12-16 11:40AM  Refinery M&A Heats Up
Jul-07-16 05:25PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers
Jul-06-16 11:38AM  [$$] Tighter Supply for Now at The Wall Street Journal
Jul-05-16 09:25AM  LyondellBasell (LYB) Stock Price Target Cut at Jefferies
04:16AM  5 Companies for Enterprising Investors Near 52-Week Lows
Jun-28-16 06:01PM  After-hours buzz: Nike, United Technologies, LyondellBasell & more at CNBC
08:04AM  LyondellBasell to Gain from Expansion Moves Amid Challenges
Jun-27-16 01:20PM  10 Most Undervalued Companies for the Enterprising Investor
12:08PM  LyondellBasell (LYB) Stock Slips on RBC Capital Downgrade
07:56AM  Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan
06:17AM  LyondellBasell downgraded by RBC Capital Mkts
Jun-26-16 05:15PM  10 Companies for Enterprising Dividend Investors - June
Jun-13-16 03:27PM  LyondellBasell Charts Tell the True Tale
09:07AM  Heres Why These Five Stocks Are In the Spotlight at Insider Monkey
08:55AM  Top Analyst Upgrades and Downgrades: AMD, Agios Pharma, Baidu, Diamond Offshore, LyondellBasell, Occidental Petroleum and More at 24/7 Wall St.
Jun-11-16 12:01AM  This Weekend's Barron's: The Midyear Roundtable with Insights from Nine Market Experts ~ No Recession in Sight ~ Retailer Williams-Sonoma Is 'Amazon-Proof' at Barrons.com
12:01AM  [$$] LyondellBasell Offers a 4.2% Yield and Upside at Barrons.com
Jun-07-16 12:44PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers
Jun-06-16 05:15PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct F
May-31-16 12:16PM  LyondellBasell to Address Deutsche Bank Global Industrials and Materials Summit PR Newswire
May-29-16 06:00PM  The Share Buyback Report: The Materials Sector (MON, LYB) at Investopedia
May-17-16 02:04PM  LyondellBasell to Address the Bernstein 32nd Annual Strategic Decisions Conference PR Newswire
May-16-16 04:03PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
06:26AM  LyondellBasell Bumps Up Dividend, Announces Share Buyback
May-13-16 09:43AM  LyondellBasell (LYB) Stock Climbs on Stock Buyback, Dividend Hike at TheStreet
08:55AM  LyondellBasell Announces New Share Repurchase Program and Increased Dividend PR Newswire
May-09-16 05:43PM  LyondellBasell Receives National MS Society Circle of Distinction Award PR Newswire
May-06-16 08:16AM  Chemical Stocks Reporting Q1 Earnings on May 9: IFF, PAH Zacks
May-02-16 04:38PM  LyondellBasell to Address Goldman Sachs Basic Materials Conference PR Newswire
08:35AM  LyondellBasell Industries NV breached its 50 day moving average in a Bearish Manner : LYB-US : May 2, 2016 at Capital Cube
Apr-29-16 03:09PM  ETFs with exposure to LyondellBasell Industries NV : April 29, 2016 at Capital Cube
10:13AM  LyondellBasell to Address Wells Fargo Securities Industrial and Construction Conference PR Newswire
Apr-28-16 01:04PM  LYONDELLBASELL INDUSTRIES N.V. Financials EDGAR Online Financials
10:50AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q1, 2016 By the Numbers at Capital Cube
Apr-27-16 08:30AM  LyondellBasell Announces Planned Departure of Sergey Vasnetsov PR Newswire
Apr-26-16 07:30AM  Greater Chicago Plans for Nearly $3.8 Billion in Projects in Coming Year, an Industrial Info News Alert Marketwired
Apr-25-16 09:58AM  LyondellBasell (LYB) Stock Price Target Raised at Barclays at TheStreet
Apr-22-16 10:57PM  Edited Transcript of LYB earnings conference call or presentation 22-Apr-16 3:00pm GMT Thomson Reuters StreetEvents
11:04AM  LyondellBasell (LYB) Trumps Q1 Earnings, Revenues Miss Zacks
09:29AM  How Will LyondellBasell (LYB) Stock React to Mixed Q1 Results? at TheStreet
08:40AM  LyondellBasell (LYB) Tops Q1 Earnings Estimates, Sales Miss Zacks
08:13AM  LyondellBasell Industries Q1 Revenue Miss Estimations Benzinga
07:17AM  LyondellBasell beats 1Q profit forecasts AP
07:07AM  Q1 2016 LyondellBasell Industries NV Earnings Release - Before Market Open CCBN
07:01AM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
07:00AM  LyondellBasell Reports First-Quarter 2016 Earnings PR Newswire
Apr-21-16 04:04PM  LyondellBasell (LYB) Stock Closed Higher Ahead of Friday's Q1 Earnings at TheStreet
Apr-20-16 10:09AM  LyondellBasell (LYB): Will Low Oil, Outages Hit Q1 Earnings? Zacks
Apr-12-16 01:56PM  Have We Seen The Bottom In Oil Prices?
11:40AM  LyondellBasell to Discuss First-Quarter Results on Friday, April 22, 2016 PR Newswire
Apr-11-16 05:30AM  Politicians Impede Prosperity
Apr-08-16 04:08PM  LyondellBasell (LYB) Stock Closed Down on Refinery Fire at TheStreet
01:12PM  No injuries reported in Houston Ship Channel refinery fire
01:00PM  Houston refinery fire out; Lyondell cuts rates at CNBC
12:15PM  Fire at LyondellBasell Houston plant
12:00PM  LyondellBasell Wraps Up Zylog's PP Compounding Assets Buy
Apr-07-16 06:26AM  LyondellBasell Completes Second Polypropylene Compounds Acquisition in India PR Newswire
Apr-06-16 09:50AM  Billionaire Andreas Halvorsens Top Long-Term Holdings at Insider Monkey
Mar-23-16 08:36AM  LyondellBasell Among the Top United Way of Greater Houston Campaigns for 2015 at noodls
08:30AM  LyondellBasell Among the Top United Way of Greater Houston Campaigns for 2015 PR Newswire
Mar-18-16 10:10AM  Stock Market News for March 18, 2016
Mar-15-16 12:30PM  LyondellBasell Poised on Expansion Initiatives Amid Headwinds
10:10AM  Stock Market News for March 15, 2016
Mar-14-16 10:45AM  How Risky Is LyondellBasell's Stock? at Motley Fool
05:30AM  ECB Goes All In Plus A Potential Oil Production Deal Boosts Market
Mar-11-16 05:35PM  LyondellBasell Honored by Junior Achievement with the US President's Volunteer Service Award PR Newswire
10:10AM  Stock Market News for March 11, 2016
Mar-09-16 10:10AM  Stock Market News for March 09, 2016
Mar-08-16 10:10AM  Stock Market News for March 08, 2016
Mar-03-16 10:20AM  RBC Makes Big Changes to Top Picks Equity Portfolio for March at 24/7 Wall St.
Mar-02-16 05:26PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:44PM  Value Income Stocks Best Positioned In Current Market
12:07PM  Hedge Funds Favorite Industrial Stocks Going Into 2016 at Insider Monkey
Mar-01-16 06:04PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:34PM  LyondellBasell Industries NV Value Analysis (NYSE:LYB) : March 1, 2016
Feb-29-16 08:13AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : February 29, 2016
Feb-25-16 02:40PM  LyondellBasell (LYB) Announces Pricing of Notes Offering
Feb-24-16 02:40PM  LyondellBasell Prices Public Offering of Guaranteed Notes PR Newswire
02:30PM  LyondellBasell to Address J.P. Morgan Aviation, Transportation & Industrials Conference PR Newswire
08:37AM  LYB International Finance II B.V. -- Moody's rates LyondellBasell's new notes Baa1, outlook stable at Moody's
Feb-23-16 10:10AM  Stock Market News for February 23, 2016
Feb-17-16 01:40PM  The Materials Sector Struggles to Cross Its 100-Day Moving Average
10:00AM  LyondellBasell to Address Bank of America Global Agriculture & Chemicals Conference PR Newswire
09:08AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Feb-16-16 04:30PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 10-K, Annual Report
Feb-10-16 03:15PM  Fluor Wins FEED Contract Again, this time for LyondellBasell
Feb-09-16 10:10AM  Stock Market News for February 09, 2016
08:02AM  The C-Suite Speaks: Inventories Destocked?
06:21AM  5 Commodity Stocks That Could Reverse Higher in February at TheStreet
Feb-08-16 04:04PM  LyondellBasell (LYB) Wraps Up Petroken Unit Sale to GIP -5.05%
LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers. The company operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Refining; and Technology. It produces and markets olefins, including ethylene, propylene, and butadiene; polyolefins, which consist of high density polyethylene, low density polyethylene, linear low density polyethylene, and polypropylene (PP); specialty polyolefins comprising PP compounds, catalloy process resins, and polybutene-1 resins; and aromatics, which include benzene. The company also produces and markets propylene oxide (PO); PO co-products, such as styrene monomers and tertiary butyl alcohol; PO derivatives consisting of propylene glycol, propylene glycol ethers, and butanediol; acetyls, including methanol, acetic acid, and vinyl acetate monomers; and ethylene derivatives, such as ethylene oxide, ethylene glycol, ethylene glycol ethers, and ethanol. In addition, it refines gasoline and components, ultra low sulfur diesel, jet fuel, lube oils, and aromatics. Further, the company develops and licenses chemical, polyolefin, and other process technologies, as well as provides associated engineering and other services; and develops, manufactures, and sells polyolefin catalysts. LyondellBasell Industries N.V. was founded in 2005 and is headquartered in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Covezzi MassimoSVP Research & DevelopmentApr 26Sale89.147,551673,1119,702Apr 26 04:28 PM
Vasnetsov SergeySVP Strategic PlanningApr 26Sale89.893,127281,0764,733Apr 26 04:28 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 09Sale82.531,100,00090,786,41077,354Mar 10 04:38 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 08Sale82.041,000,00082,042,77779,646Mar 10 04:38 PM
Wolf Jacquelyn HSVP, Human ResourcesNov 19Sale94.601,944183,9028,627Nov 20 11:45 AM
Wolf Jacquelyn HSVP, Human ResourcesNov 18Option Exercise58.9715,026886,14523,159Nov 20 11:45 AM
Wolf Jacquelyn HSVP, Human ResourcesNov 18Sale94.441,450136,93220,306Nov 20 11:45 AM
AI INTERNATIONAL CHEMICALS S.A10% OwnerOct 30Sale92.402,270,000209,745,03180,642Oct 30 07:57 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerOct 29Sale92.24880,00081,169,26482,903Oct 30 07:57 PM
Covezzi MassimoSVP Research & DevelopmentOct 28Sale90.913,000272,73514,266Oct 29 10:42 AM
AI INTERNATIONAL CHEMICALS S.A10% OwnerOct 28Sale92.34850,00078,487,72583,780Oct 30 07:57 PM
Vasnetsov SergeySVP Strategic PlanningOct 09Sale97.2936,5533,556,2522,140Oct 14 06:01 PM
Somma Lawrence CVice President and TreasurerSep 09Buy84.64141,1853,510Sep 11 05:03 PM
CARROLL MILTONDirectorSep 03Sale84.003,000252,0001,901Sep 03 04:12 PM
CARROLL MILTONDirectorAug 31Sale85.201,500127,8064,901Sep 02 05:17 PM
ALLEN WILLIAM B JRVP FinanceAug 25Buy80.3340032,1325,743Aug 25 04:32 PM
Coombs Daniel MEVP - I&DAug 12Buy88.1856049,3811,847Aug 13 12:53 PM
TMO Thermo Fisher Scientific, Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific, Inc.
IndexS&P 500 P/E31.52 EPS (ttm)4.98 Insider Own0.20% Shs Outstand395.80M Perf Week-0.10%
Market Cap62.10B Forward P/E17.49 EPS next Y8.97 Insider Trans-33.69% Shs Float392.91M Perf Month4.70%
Income2.00B PEG3.00 EPS next Q2.01 Inst Own89.80% Short Float1.30% Perf Quarter6.94%
Sales17.34B P/S3.58 EPS this Y4.60% Inst Trans0.03% Short Ratio3.56 Perf Half Y16.19%
Book/sh52.87 P/B2.97 EPS next Y10.31% ROA- Target Price167.12 Perf Year12.08%
Cash/sh- P/C- EPS next 5Y10.50% ROE- 52W Range116.73 - 158.37 Perf YTD10.83%
Dividend0.60 P/FCF- EPS past 5Y15.00% ROI7.00% 52W High-0.93% Beta1.02
Dividend %0.38% Quick Ratio0.70 Sales past 5Y10.30% Gross Margin45.50% 52W Low34.41% ATR2.29
Employees52000 Current Ratio1.00 Sales Q/Q9.60% Oper. Margin- RSI (14)62.00 Volatility0.98% 1.48%
OptionableYes Debt/Eq0.72 EPS Q/Q5.20% Profit Margin- Rel Volume0.62 Prev Close156.20
ShortableYes LT Debt/Eq0.56 EarningsJul 28 BMO Payout- Avg Volume1.44M Price156.89
Recom1.70 SMA203.70% SMA504.16% SMA20012.51% Volume894,100 Change0.44%
May-27-16Reiterated Mizuho Buy $166 → $170
May-19-16Reiterated Mizuho Buy $163 → $166
May-03-16Reiterated Mizuho Buy $160 → $163
Apr-29-16Downgrade Jefferies Buy → Hold
Apr-04-16Reiterated Mizuho Buy $150 → $160
Mar-02-16Reiterated Topeka Capital Markets Buy $145 → $155
Jan-11-16Reiterated Stifel Buy $150 → $158
Jan-07-16Initiated Deutsche Bank Buy $160
Oct-06-15Initiated Argus Buy $145
Jul-23-15Reiterated Mizuho Buy $150 → $160
May-21-15Reiterated Barclays Overweight $160 → $165
Mar-10-15Initiated UBS Buy $160
Jan-21-15Reiterated Robert W. Baird Outperform $142 → $144
Aug-12-14Initiated Stifel Buy $150
Jan-30-14Reiterated Mizuho Buy $130 → $140
Jan-30-14Reiterated ISI Group Buy $121.50 → $130
Jan-10-14Reiterated UBS Buy $107 → $127
Jan-06-14Reiterated ISI Group Buy $111 → $121.50
Sep-10-13Reiterated Mizuho Buy $100 → $110
Jul-25-13Reiterated UBS Buy $96 → $101
Jul-22-16 09:51AM  4 Medical Instrument Stocks to Bet on This Earnings Season
Jul-20-16 03:02PM  Thermo Fisher (TMO) Q2 Earnings: Surprise in Store?
Jul-15-16 01:01PM  Yum!, Pepsi Among 10 NYSE Stocks Hitting 52-Week Highs Thursday at Insider Monkey
09:00AM  London-Based Cryder Capital Loads Up On Top Picks; Sells Off BlackRock at Insider Monkey
Jul-14-16 08:41PM  Abbott Laboratories: Analyst Recommendations before 2Q16 Results
10:06AM  How Harvard Bioscience deals with the pros and cons of its own name at bizjournals.com
Jul-13-16 06:02PM  MedTech Tailwinds at a Glance: Which Stocks to Buy?
11:04AM  Can Thermo Fishers PPI Business System Continue to Drive Growth in 2016?
10:29AM  What Analysts Recommend ahead of Johnson & Johnsons 2Q16 Results
09:04AM  What Are Thermo Fishers Major Growth Catalysts in 2016?
Jul-12-16 09:05PM  Can Thermo Fishers Capital Allocation Strategy Keep Enhancing Shareholder Value?
08:08PM  How Innovation Is Driving Thermo Fisher Scientifics Growth
08:06PM  How Are Thermo Fishers Commercial Capabilities Driving Its Share Gains?
05:08PM  How Does Varian Medical Systems Valuation Compare to Peers?
09:08AM  What Lies Ahead for Thermo Fishers Life Sciences Solutions Business?
Jul-11-16 05:17PM  What Will Hillary Clinton's Plan Do For Medical Hardware Stocks?
12:06PM  Inside Thermo Fisher Scientifics Emerging Markets Strategy
08:56AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : July 11, 2016
05:05AM  5 Stocks Hit 52-Week High Prices
Jul-08-16 11:29AM  Understanding Thermo Fisher Scientifics Valuation among Peers
11:29AM  Most Analysts Recommend a Buy for Thermo Fisher Scientific
11:15AM  New Cell Culture Plate Eliminates Edge Effect during Extended Incubation Business Wire
09:08AM  Understanding Thermo Fisher Scientifics Financial Model
Jul-07-16 04:30PM  Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $1.5 Billion of Share Repurchases Business Wire
09:00AM  Medical Device Consolidation Frenzy: Here's How to Play it
Jul-05-16 05:30PM  Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2016 Business Wire
04:09PM  Illumina Downgraded On Outlook For Cancer, Academic Research
12:08PM  How is Medtronics Economic Value Strategy Driving its Growth?
Jul-01-16 05:01PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
Jun-28-16 09:05AM  Top money managers take temperature of health stocks: 'Genomics' firms to soar at CNBC
08:00AM  Hunting for health-care winners
Jun-27-16 09:39AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : June 27, 2016
09:36AM  U.S. Supreme Court to hear genetic-testing kit patent fight
Jun-20-16 08:17AM  Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Jun-17-16 12:25PM  Thermo Fisher Scientific, Inc. Value Analysis (NYSE:TMO) : June 17, 2016
Jun-16-16 03:55PM  Heres what FEI's CEO had to say to employees about the impending sale at bizjournals.com
Jun-15-16 08:39AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : June 15, 2016
Jun-13-16 08:00AM  Thermo Fisher Scientific and West China Hospital Partner on Joint Research Platform for Precision Medicine Business Wire
Jun-09-16 09:18AM  Premarket Research Report Covering the Medical Laboratories and Research Industry
Jun-08-16 03:33PM  There's a new most-valuable public company in the Bay State until August at bizjournals.com
03:11PM  More Momentum Seen for Thermo Fisher at TheStreet
09:08AM  Thermo Fisher (TMO) Stock Price Target Upped at Keybanc
06:00AM  'Mad Money' Lightning Round: Buy, Buy, Buy Time Warner
Jun-07-16 12:30PM  5 Companies Achieve 5a-Week Highs
Jun-06-16 08:00AM  Thermo Fisher Scientific Strengthens Life Sciences Leadership with New Instruments Launched at ASMS 2016 Business Wire
May-31-16 03:09PM  FEI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FEI Company PR Newswire
01:30PM  Thermo Fisher Scientific Inc. -- Moody's affirms Thermo Fisher's ratings following FEI acquisition announcement; outlook positive at Moody's
10:48AM  Milberg LLP Announces Investigation of Purchase of FEI Company by Thermo Fisher Scientific Inc. PR Newswire
10:07AM  Wide Ranging Interview With Larry Robbins On The Future Of Hedge funds And More
08:58AM  Thermo Fisher to Buy FEI, Boost Electron Microscopy Platform
08:32AM  How to Invest in the Life Cycle of a Drug at Motley Fool
May-30-16 02:31PM  Five Capital Goods Stocks Hedge Funds Are Betting On at Insider Monkey
May-27-16 07:30PM  Week in Review: S&P 500 Closes Best Week Since March
05:40PM  Thermo Fisher Buys Microscope Tech Specialist FEI at Investopedia
05:23PM  Thermo Fisher Buying FEI, Expanding In White Hot Pharma Market
04:59PM  Thermo Fisher Scientific acquires FEI Co. for $4.2 Billion at USA TODAY
04:09PM  Wall Street Enters Long Weekend With Fed on the Brain
03:02PM  Stocks Inch Higher as Yellen Hints at Summer Rate Hike
02:43PM  Thermo Fisher Acquisition of FEI Brings "Terrific Complementarity" While FEI Is a Sell at TheStreet
02:00PM  Thermo Fisher To Buy FEI for $4.2B in Cash at TheStreet
01:34PM  FEI (FEIC) Stock Skyrockets on $4.2 Billion Thermo Fisher Acquisition, Jim Cramer's Take at TheStreet
01:11PM  [$$] Palo Alto Networks shares slump on slower sales growth at Financial Times
12:57PM  Stocks Maintain Slight Gains Ahead of Yellen Speech
12:17PM  Thermo Fisher to buy microscope maker FEI Co for about $4.2 bln Reuters
11:59AM  FEI Company (FEIC) Spikes 14% As Thermo Fisher (TMO) Agrees to Acquire Company at Insider Monkey
11:57AM  FEI Company's Stock Surges on Thermo Fisher Scientific Inc. Buyout at Motley Fool
11:08AM  Mild Gains For Stocks; Thermo Fisher Buys FEI For $4.2 Billion
10:43AM  Jim Cramer: Stay Long Thermo Fisher, Sell FEI at TheStreet
10:36AM  Thermo Fisher Adds Electron Microscopy Specialist FEI in $4.2B Deal at TheStreet
10:25AM  Jim Cramer -- Thermo Fishers Acquisition, CEO Are Great
09:57AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of FEI Company to Thermo Fisher Scientific Inc. - FEIC Accesswire
09:26AM  Stocks to Watch: Big Lots, Thermo Fisher, FEI, Williams, Energy Transfer at The Wall Street Journal
09:23AM  Cramer's Mad Dash: Thermo Fisher
09:18AM  Deals of the Day: Thermo Fisher Nabs FEI, Twilio Takes the Plunge, Ackman on Other Side at The Wall Street Journal
09:15AM  Stock Futures Set Up for Flat Start as First-Quarter GDP Rises
08:55AM  First-Quarter GDP Revised Upward; Futures Indicate Higher Opening
08:36AM  Thermo Fisher Scientific plans to buy FEI in $4.2 billion deal at MarketWatch
08:06AM  FEI (FEIC) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of FEI Company; Are FEI Shareholders Getting a Fair Price? PR Newswire
07:56AM  Early movers: BIG, VRX, GOOGL, ULTA, FEIC, GME, DECK, VZ, PANW & more at CNBC
07:48AM  Thermo Fisher to buy FEI Co for about $4.2 bln Reuters
07:39AM  Thermo Fisher to Buy FEI for $4.2 Billion at TheStreet
07:20AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:13AM  Thermo Fisher to buy FEI in a $4.2 billion cash deal at MarketWatch
07:07AM  Thermo Fisher Scientific to Buy FEI for About $4.2 Billion at Bloomberg
07:00AM  Thermo Fisher Scientific to Acquire FEI Company Business Wire
May-26-16 03:06PM  What Do Analysts Recommend for Medtronic ahead of 4Q16 Results?
08:20AM  3 Stocks That Help Drugmakers Create Billion Dollar Blockbusters at Motley Fool
06:00AM  'Mad Money' Lightning Round: I'm Buying Buffett's Berkshire Hathaway
May-25-16 06:00AM  Jim Cramer's Top Takeaways: Exxon, Schlumberger, Nike, Under Armour, Thermo Fisher Scientific
May-24-16 06:58PM  Cramer Remix: Why bad news is good news for the market at CNBC
May-19-16 04:11PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Change in Directors or Principal Officers
May-18-16 04:30PM  Thermo Fisher Scientific Declares Quarterly Dividend Business Wire
07:40AM  Thermo Fisher Posts Solid Q1; Affimetrix Integration Continues
May-17-16 09:32AM  Citadel Investment Groups Biggest Q1 Moves Highlight Reduced Exposure To U.S Equities at Insider Monkey
May-16-16 05:48PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Other Events
May-12-16 01:04PM  THERMO FISHER SCIENTIFIC INC. Financials
May-10-16 08:00AM  Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility Business Wire
May-06-16 08:33AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
May-05-16 01:22AM  PRWCX: T Rowe Price Capital Appreciation Fund Top 5 Holdings Analysis at Investopedia
May-04-16 08:41PM  Sohn Investment Conference 2016 Full Wrap Up Yahoo Finance Contributors
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company's Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company's Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Loewald Thomas WSenior Vice PresidentJul 13Option Exercise73.248,025587,75152,194Jul 14 04:35 PM
Loewald Thomas WSenior Vice PresidentJul 13Sale155.008,0251,243,87544,169Jul 14 04:35 PM
CASPER MARC NChief Executive OfficerJul 05Option Exercise54.9720,0001,099,400340,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 05Sale147.6920,0002,953,804320,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Option Exercise54.9730,0001,649,100350,998Jul 06 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Sale148.8530,0004,465,638320,998Jul 06 04:42 PM
Shine Daniel PSenior Vice PresidentJun 15Option Exercise54.976,900379,29328,779Jun 16 05:00 PM
Shine Daniel PSenior Vice PresidentJun 15Sale148.316,9001,023,35621,879Jun 16 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Option Exercise54.9768,2003,748,954138,777Jun 14 04:47 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Sale152.3868,20010,392,63370,577Jun 14 04:47 PM
MANZI JIM PDirectorJun 03Sale153.001,137173,96138,733Jun 06 04:41 PM
Loewald Thomas WSenior Vice PresidentJun 02Option Exercise73.2415,0001,098,60059,169Jun 06 04:39 PM
Loewald Thomas WSenior Vice PresidentJun 02Sale152.8415,0002,292,60044,169Jun 06 04:39 PM
Williamson StephenSr. VP and CFOMay 25Option Exercise54.973,740205,58833,821May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Option Exercise54.978,660476,04038,741May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Sale150.298,6601,301,48330,081May 26 04:38 PM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Option Exercise68.386,357434,69425,671May 17 11:39 AM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Sale150.007,8111,171,65017,860May 17 11:39 AM
Shine Daniel PSenior Vice PresidentApr 26Option Exercise54.975,000274,85027,892Apr 27 04:09 PM
Shine Daniel PSenior Vice PresidentApr 26Sale146.006,013877,89821,879Apr 27 04:09 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Option Exercise73.2410,000732,40046,937Apr 07 04:28 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Sale141.8610,0001,418,58036,937Apr 07 04:28 PM
Durbin Patrick MSenior Vice PresidentApr 04Option Exercise64.3911,250724,37944,348Apr 06 04:21 PM
Durbin Patrick MSenior Vice PresidentApr 04Sale142.1816,2502,310,42528,098Apr 06 04:21 PM
Williamson StephenSr. VP and CFOMar 22Option Exercise51.634,592237,07830,081Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Option Exercise51.7510,708554,09536,197Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Sale139.5010,7081,493,76625,489Mar 23 04:36 PM
CASPER MARC NChief Executive OfficerMar 14Sale139.2830,0004,178,296320,998Mar 16 05:40 PM
Malus Alan JExecutive Vice PresidentMar 10Option Exercise126.3925,9253,276,78873,211Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 10Sale139.0525,9253,604,80947,286Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 09Option Exercise73.2411,525844,09162,732Mar 11 04:07 PM
Malus Alan JExecutive Vice PresidentMar 09Sale138.5015,4462,139,29047,286Mar 11 04:07 PM
SPERLING SCOTT MDirectorMar 03Option Exercise36.8720,000737,40085,790Mar 07 04:31 PM
Loewald Thomas WSenior Vice PresidentMar 03Option Exercise49.493,625179,40147,794Mar 04 07:15 PM
Loewald Thomas WSenior Vice PresidentMar 03Sale137.283,625497,64044,169Mar 04 07:15 PM
SPERLING SCOTT MDirectorMar 03Sale137.905,350737,74580,440Mar 07 04:31 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Mar 01Sale135.002,951398,38536,937Mar 02 05:12 PM
Shine Daniel PSenior Vice PresidentFeb 29Sale130.2461479,96722,892Mar 02 04:50 PM
Shine Daniel PSenior Vice PresidentFeb 26Option Exercise54.975,000274,85030,089Mar 01 05:30 PM
Shine Daniel PSenior Vice PresidentFeb 26Sale131.006,180809,58023,909Mar 01 05:30 PM
Malus Alan JExecutive Vice PresidentFeb 01Option Exercise59.04103,4006,105,022149,221Feb 02 04:41 PM
Malus Alan JExecutive Vice PresidentFeb 01Sale130.24103,40013,467,21145,821Feb 02 04:41 PM
Loewald Thomas WSenior Vice PresidentDec 14Option Exercise54.977,013385,50544,451Dec 16 03:47 PM
Loewald Thomas WSenior Vice PresidentDec 14Sale134.1813,0131,746,08431,438Dec 16 03:47 PM
Parrett William GDirectorDec 11Buy134.161,000134,16014,636Dec 15 03:36 PM
Malus Alan JExecutive Vice PresidentDec 07Option Exercise49.4982,3004,073,027128,121Dec 08 05:07 PM
Malus Alan JExecutive Vice PresidentDec 07Sale135.4982,30011,150,96345,821Dec 08 05:07 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Nov 04Sale135.001,692228,42033,415Nov 05 04:26 PM
HARRIS C MARTINDirectorNov 03Sale134.3553171,3404,038Nov 04 05:53 PM
MANZI JIM PDirectorNov 02Sale133.493,050407,14538,870Nov 03 05:33 PM
CASPER MARC NChief Executive OfficerSep 17Sale130.0025,0003,250,000360,607Sep 18 04:36 PM
Malus Alan JExecutive Vice PresidentAug 28Sale127.554,557581,24545,821Sep 01 05:07 PM
CRM salesforce.com, inc. daily Stock Chart
CRM [NYSE]
salesforce.com, inc.
IndexS&P 500 P/E- EPS (ttm)-0.02 Insider Own0.10% Shs Outstand670.52M Perf Week1.41%
Market Cap55.35B Forward P/E62.78 EPS next Y1.32 Insider Trans-75.25% Shs Float639.36M Perf Month2.39%
Income-12.80M PEG- EPS next Q0.22 Inst Own87.80% Short Float1.80% Perf Quarter7.94%
Sales7.07B P/S7.83 EPS this Y83.00% Inst Trans-0.20% Short Ratio3.07 Perf Half Y15.37%
Book/sh8.24 P/B10.02 EPS next Y38.42% ROA-0.10% Target Price97.23 Perf Year14.32%
Cash/sh3.03 P/C27.25 EPS next 5Y29.23% ROE-0.30% 52W Range52.60 - 84.48 Perf YTD5.29%
Dividend- P/FCF33.92 EPS past 5Y-21.10% ROI0.00% 52W High-2.28% Beta1.58
Dividend %- Quick Ratio0.70 Sales past 5Y32.10% Gross Margin75.00% 52W Low56.94% ATR1.39
Employees19000 Current Ratio0.70 Sales Q/Q26.80% Oper. Margin1.90% RSI (14)57.82 Volatility1.47% 1.59%
OptionableYes Debt/Eq0.37 EPS Q/Q816.10% Profit Margin-0.20% Rel Volume0.69 Prev Close81.70
ShortableYes LT Debt/Eq0.37 EarningsAug 18 AMC Payout- Avg Volume3.75M Price82.55
Recom1.80 SMA202.92% SMA502.21% SMA2009.11% Volume2,571,700 Change1.04%
Jun-15-16Initiated BMO Capital Markets Outperform $98
May-19-16Reiterated Wunderlich Buy $93 → $101
May-19-16Reiterated Wedbush Outperform $95 → $98
May-19-16Reiterated Stifel Buy $85 → $93
May-19-16Reiterated MKM Partners Buy $86 → $96
May-19-16Reiterated Mizuho Buy $90 → $100
May-19-16Reiterated Canaccord Genuity Buy $88 → $95
May-19-16Reiterated Barclays Overweight $88 → $89
May-17-16Reiterated Jefferies Hold $60 → $74
May-12-16Reiterated Barclays Overweight $72 → $88
Mar-04-16Initiated Macquarie Outperform
Feb-25-16Reiterated Wedbush Outperform $92 → $95
Feb-25-16Reiterated FBR Capital Outperform $88 → $82
Feb-25-16Reiterated Barclays Overweight $67 → $72
Feb-10-16Upgrade Credit Agricole Outperform → Buy
Feb-10-16Reiterated Barclays Overweight $90 → $67
Feb-09-16Upgrade Jefferies Underperform → Hold
Dec-18-15Upgrade Wedbush Neutral → Outperform
Nov-20-15Reiterated DA Davidson Neutral $75 → $87
Nov-19-15Reiterated Wunderlich Buy $85 → $93
Jul-25-16 12:29AM  [$$] Salesforce Would Have Bid Much Higher for LinkedIn at The Wall Street Journal
Jul-24-16 11:37PM  Salesforce would have outbid Microsoft for LinkedIn, Benioff says at MarketWatch
11:26PM  [$$] Salesforce Would Have Bid 'Much Higher' for LinkedIn at The Wall Street Journal
10:12PM  [$$] Salesforce Had Plans For Higher LinkedIn Bid at The Wall Street Journal
Jul-22-16 09:35PM  [$$] Salesforce Would Have Bid 'Much Higher' for LinkedIn at The Wall Street Journal
04:08PM  The 5 Stocks With The Most Bullish Sentiment Right Now Benzinga
03:02PM  ETFs with exposure to salesforce.com, inc. : July 22, 2016
02:37PM  [$$] Salesforce to Acquire Coolan for Infrastructure Analytics at The Wall Street Journal
10:02AM  Clouds With a Golden Lining: Enterprise Software M&A Could Fly Sky High
09:30AM  How Did Microsofts Cloud Offerings Perform in Fiscal 4Q16?
Jul-21-16 10:50PM  Why The NBA Is Pulling Its All-Star Game Out of North Carolina at Fortune
04:44PM  Top-Rated Apple Supplier Leads 5 Stocks Poised To Break Out
01:19PM  These Top Stocks Could Soon Provide Buying Opportunities
11:28AM  Morgan Stanley Ups Salesforce.com Target, Sees $20B In Revenue Ahead at Barrons.com
09:46AM  Why Companies Overpay For Acquisitions at Forbes
Jul-20-16 11:18PM  Apple Security Bug Lets Hackers Nab Your Mac and iPhone Passwords With 1 Text at Fortune
03:45PM  SAP Flying High Following Record Q2 Earnings at Investopedia
02:29AM  Apple FaceTime Flaw Lets Snoops Listen to Your Calls at Fortune
Jul-19-16 01:35PM  Tuesday links: shrinking alpha odds
11:42AM  [$$] Salesforce and Expedia highlight valuation disparity at Financial Times
Jul-18-16 09:04PM  Google's Android has gotten so out of control that $55 billion Salesforce had to take drastic measures Business Insider
04:30PM  Is the End Near for this Tech Giant?
09:54AM  Business leaders like Clinton more than Trump
07:00AM  [$$] Tech investing: second derivatives at Financial Times
Jul-16-16 12:40PM  Trump VP Pick Mike Pence's Indiana Record Shows Preference for Social Issues Over Business
Jul-15-16 10:06AM  Understanding SAPs Rapid Growth in the SaaS Space in 2015
08:57AM  Pence Pick Wont Help Donald Trump With This Constituency at Fortune
07:00AM  Amazon Buys a Cloud Software Firm; Google Faces New E.U. Charges; Cypress Gains on M&A Rumor
Jul-14-16 09:00PM  The One Thing That Matters More Than Perks to Attract the Best Talent at Fortune
05:29PM  Top 5 Mutual Fund Holders of Salesforce.com (CRM, ORCL) at Investopedia
04:41PM  HubSpot, Zendesk Price Targets Hiked On Potential Market Size at Investor's Business Daily
02:59PM  Amazon Just Bought This Hot Cloud Startup at Fortune
02:55PM  Trump VP choice Mike Pence is a frenemy of business
10:47AM  Demandware Is 'Best Ecommerce Cloud Asset' For CRM: UBS at Barrons.com
08:00AM  Easter Seals Bay Area Teams With Salesforce to Drive Digital Transformation in Health Services PR Newswire
Jul-13-16 09:47AM  Salesforce (CRM) Closes Demandware Acquisition for $2.8B
08:36AM  Data SheetWednesday, July 13, 2016 at Fortune
08:08AM  Tech action in the Valley
Jul-12-16 04:50PM  The Midwestern state becoming a tech jobs mecca at CNBC
05:11AM  Tech's sizzling summer stocks
Jul-11-16 05:30PM  SALESFORCE COM INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispo
04:53PM  The Salesforce Conundrum: Profit Versus Growth Gurufocus
04:22PM  Jhonsa: Microsoft's Deal with GE Shows the Cloud Isn't All Just About Amazon
03:34PM  Coca-Cola CIO Pushed a Cloud Agenda at The Wall Street Journal
01:25PM  Salesforce.com Finalizes Demandware Acquisition at Investopedia
09:15AM  Salesforce Completes Acquisition of Demandware PR Newswire
08:21AM  salesforce.com, inc. breached its 50 day moving average in a Bullish Manner : CRM-US : July 11, 2016
08:00AM  Salesforce Completes Tender Offer for Outstanding Shares of Demandware PR Newswire
Jul-08-16 03:33PM  Jhonsa: Heres Why Oracle Is Pulling Out all the Stops to Boost Its Cloud Profits at TheStreet
Jul-07-16 01:14PM  Beginning of a new bull run
09:20AM  Like Growth? Then You'll Love These 3 Stocks at Motley Fool
08:54AM  Jhonsa: Microsoft's Latest Moves Ought to Make SAP and Oracle a Little Nervous at TheStreet
08:52AM  Oracle vs. Salesforce: Who Will Get to $10 Billion in Cloud Revenue First? at TheStreet
08:00AM  Salesforce.org Expands Force for Change Grants Program by More Than 300 Percent to Accelerate Social Impact PR Newswire
Jul-06-16 10:13PM  2016 Second Half Outlook
09:06PM  A Look into Oracles Margin Growth in Fiscal 2016
07:30PM  Bill Gates helped negotiate Microsoft-LinkedIn deal after Salesforce started bidding war at bizjournals.com
08:31AM  Data SheetWednesday, July 6, 2016 at Fortune
Jul-05-16 02:12PM  ServiceMax to Participate in Salesforces First Invest in Japan with JETRO Seminar Business Wire
01:21PM  Salesforce Wasn't Microsoft's Only Rival for LinkedIn, and That's Good News for Twitter Investors at TheStreet
11:28AM  Another lease at Vanguard Center signals vibrant submarket activity at bizjournals.com
Jul-04-16 10:18PM  Large-Cap Growth Fund Is Counting on a Rebound at The Wall Street Journal
Jul-03-16 09:00AM  Did Microsoft Acquire LinkedIn for the Cloud Business? (MSFT, LNKD) at Investopedia
Jul-02-16 02:47PM  Bidding from Salesforce pushed Microsoft to raise its offer for LinkedIn at MarketWatch
Jul-01-16 10:09PM  [$$] Salesforce Bids Pushed Microsoft to Raise LinkedIn Offer at The Wall Street Journal
07:30PM  [$$] Bid war fuelled Microsoft's LinkedIn bill at Financial Times
05:37PM  LinkedIn shopped itself to at least 4 other companies before selling to Microsoft
08:48AM  Salesforce-Demandware Deal Gets All Regulatory Approvals
Jun-30-16 04:15PM  Salesforce and Demandware Receive All Required Regulatory Approvals PR Newswire
12:34PM  Salesforce CEO Marc Benioff says he won't be Hillary Clinton's running mate Business Insider
09:09AM  Research Report Initiated on Select Application Software Equities
09:09AM  Research Report Initiated on Select Application Software Equities Company Spotlight
Jun-29-16 02:56PM  So, What Happened To Salesforce.com's Beautiful Breakout? A 2016 Market Lesson
02:19PM  What Birchboxs VC Funding Problem Says About the Tech Bubble at Fortune
12:29PM  Why IBM and Amazon Invested Billions in the UK
09:47AM  Shopify: Monness Starts Cloud Co. at Buy on Biz Trends, Possible Takeout at Barrons.com
Jun-28-16 05:05PM  Adobe Digital Marketing Performance in Fiscal 2Q16 at Market Realist
03:41PM  Salesforce CEO Marc Benioff slams UK government leaders for doing 'too little, too late'
02:20PM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Demandware, Inc. Regarding the Sale of the Company to salesforce.com inc. - DWRE PR Newswire
01:31PM  Cisco Continues Acquisition Spree With a Big Bet on Cloud Security
11:50AM  Salesforce and Demandware: A Match Made in Clouds?
09:25AM  Cisco acquiring Massachusetts cybersecurity company for $293M at bizjournals.com
09:08AM  Adobe and Other Tech Players Want More Digital Marketing Space
08:00AM  Salesforce and Microsoft Tighten Ties. Again. at Fortune
08:00AM  Salesforce and Microsoft Deliver Salesforce Lightning for Outlook--Unifying the World's #1 CRM and Business Email Services PR Newswire
Jun-27-16 10:55PM  Benioff on Linkedin deal: Microsoft had the most cash
12:04PM  What Are Analysts Recommendations for Salesforces Stock?
11:38AM  Tech crackdowns after Brexit?
11:05AM  Where Does Salesforce Stand in the Software Space?
08:36AM  salesforce.com, inc. breached its 50 day moving average in a Bearish Manner : CRM-US : June 27, 2016
08:00AM  Salesforce Delivers '2016 Connected Patient Report' PR Newswire
08:00AM  Salesforce Chairman and CEO Marc Benioff to Participate in the World Economic Forum Annual Meeting of the New Champions 2016 PR Newswire
Jun-25-16 12:01AM  [$$] Australian Hedge Fund Posts Big Gains by Avoiding Commodities at Barrons.com
Jun-24-16 08:37PM  Salesforce is way behind Oracle, Microsoft, and SAP in one important area of its business Business Insider
07:35PM  Tech stocks slammed
05:28PM  ETFs with exposure to salesforce.com, inc. : June 24, 2016
05:10PM  Brexit Spoils Software M&A Lift: Salesforce, Adobe, Workday Fall at Investor's Business Daily
05:04PM  Salesforce.com, ServiceNow, Adobe 'Pricing Power' Spark Buy Ratings at Investor's Business Daily
04:56PM  A Look at Adobes Operating Segments in Fiscal 2Q16 at Market Realist
04:45PM  Tech plunges after UK vote
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. It offers enterprise cloud computing applications and platform services, including Sales Cloud that enables companies to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices. The company also provides Service Cloud that enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud, which enables companies to plan, personalize, and optimize customer interactions. In addition, it offers Community Cloud that enables companies to engage with groups of people by giving them access to information, applications, and experts; Analytics Cloud, an application, which enables companies to deploy sales, service, marketing, and custom analytics applications using various data source; Internet of Things Cloud that enables customers to process data, as well as build personalized actions and engage with customers in real time; and App Cloud, an application development platform for companies to deliver connected applications for various business needs. In addition, the company provides professional services, including consulting, deployment, training, and design and integration services to facilitate the adoption of its cloud solutions, as well as offers various education service offerings ranging from introductory online courses to advanced architecture certifications. It sells and markets services primarily through its direct sales force, as well as through consulting firms, systems integrators, and regional partners. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benioff MarcChairman of the Board & CEOJul 22Option Exercise27.0612,500338,28135,383,000Jul 22 05:35 PM
Benioff MarcChairman of the Board & CEOJul 22Sale82.2612,5001,028,30735,370,500Jul 22 05:35 PM
Benioff MarcChairman of the Board & CEOJul 21Option Exercise27.0612,500338,28135,383,000Jul 21 07:29 PM
BLOCK KEITHPres., Vice Chairman and COOJul 21Option Exercise37.9510,000379,50010,000Jul 21 07:34 PM
Benioff MarcChairman of the Board & CEOJul 21Sale82.0612,5001,025,72235,370,500Jul 21 07:29 PM
BLOCK KEITHPres., Vice Chairman and COOJul 21Sale82.6810,000826,8200Jul 21 07:34 PM
Benioff MarcChairman of the Board & CEOJul 20Option Exercise27.0612,500338,28135,383,000Jul 20 06:25 PM
Benioff MarcChairman of the Board & CEOJul 20Sale82.3012,5001,028,75135,370,500Jul 20 06:25 PM
Benioff MarcChairman of the Board & CEOJul 19Option Exercise27.0612,500338,28135,383,000Jul 19 08:41 PM
BLOCK KEITHPres., Vice Chairman and COOJul 19Option Exercise37.9510,000379,50010,000Jul 19 08:43 PM
Harris ParkerCo-FounderJul 19Option Exercise27.065,000135,31337,620Jul 19 08:49 PM
Roos John VictorDirectorJul 19Sale81.4015512,61717,385Jul 19 08:38 PM
Benioff MarcChairman of the Board & CEOJul 19Sale81.3912,5001,017,33435,370,500Jul 19 08:41 PM
BLOCK KEITHPres., Vice Chairman and COOJul 19Sale81.4710,000814,6780Jul 19 08:43 PM
Harris ParkerCo-FounderJul 19Sale81.395,000406,93932,620Jul 19 08:49 PM
Benioff MarcChairman of the Board & CEOJul 18Option Exercise27.0612,500338,28135,383,000Jul 18 07:59 PM
Benioff MarcChairman of the Board & CEOJul 18Sale81.7512,5001,021,86035,370,500Jul 18 07:59 PM
Benioff MarcChairman of the Board & CEOJul 15Option Exercise27.0612,500338,28135,383,000Jul 15 07:08 PM
Benioff MarcChairman of the Board & CEOJul 15Sale81.4112,5001,017,58035,370,500Jul 15 07:08 PM
Conway CraigDirectorJul 15Sale81.8640032,7449,268Jul 15 07:11 PM
BLOCK KEITHPres., Vice Chairman and COOJul 14Option Exercise37.9510,000379,50010,000Jul 14 07:23 PM
Benioff MarcChairman of the Board & CEOJul 14Option Exercise27.0612,500338,28135,383,000Jul 14 07:31 PM
BLOCK KEITHPres., Vice Chairman and COOJul 14Sale81.7010,000816,9930Jul 14 07:23 PM
Benioff MarcChairman of the Board & CEOJul 14Sale81.6712,5001,020,92535,370,500Jul 14 07:31 PM
Benioff MarcChairman of the Board & CEOJul 13Option Exercise27.0612,500338,28135,383,000Jul 13 05:37 PM
Benioff MarcChairman of the Board & CEOJul 13Sale81.6412,5001,020,53235,370,500Jul 13 05:37 PM
Benioff MarcChairman of the Board & CEOJul 12Option Exercise27.0612,500338,28135,383,000Jul 12 08:08 PM
Harris ParkerCo-FounderJul 12Option Exercise27.065,000135,31337,620Jul 12 08:22 PM
BLOCK KEITHPres., Vice Chairman and COOJul 12Option Exercise37.9510,000379,50010,000Jul 12 06:03 PM
Roos John VictorDirectorJul 12Sale81.9415512,70117,540Jul 12 08:02 PM
Benioff MarcChairman of the Board & CEOJul 12Sale81.9212,5001,024,00035,370,500Jul 12 08:08 PM
Harris ParkerCo-FounderJul 12Sale81.925,000409,60132,620Jul 12 08:22 PM
BLOCK KEITHPres., Vice Chairman and COOJul 12Sale81.5710,000815,7050Jul 12 06:03 PM
Benioff MarcChairman of the Board & CEOJul 11Option Exercise27.0612,500338,28135,383,000Jul 11 05:50 PM
Benioff MarcChairman of the Board & CEOJul 11Sale81.5712,5001,019,66035,370,500Jul 11 05:50 PM
BLOCK KEITHPres., Vice Chairman and COOJul 08Option Exercise37.9540,0001,518,00040,000Jul 08 09:24 PM
Benioff MarcChairman of the Board & CEOJul 08Option Exercise27.0612,500338,28135,383,000Jul 08 09:35 PM
BLOCK KEITHPres., Vice Chairman and COOJul 08Sale81.0040,0003,240,0000Jul 08 09:24 PM
Benioff MarcChairman of the Board & CEOJul 08Sale80.7512,5001,009,32635,370,500Jul 08 09:35 PM
Benioff MarcChairman of the Board & CEOJul 07Option Exercise27.0612,500338,28135,383,000Jul 08 09:35 PM
Benioff MarcChairman of the Board & CEOJul 07Sale78.7712,500984,57035,370,500Jul 08 09:35 PM
TOMLINSON LAWRENCEDirectorJul 07Sale78.501,600125,60027,029Jul 08 08:19 PM
Benioff MarcChairman of the Board & CEOJul 06Option Exercise27.0612,500338,28135,383,000Jul 08 09:35 PM
Benioff MarcChairman of the Board & CEOJul 06Sale78.3612,500979,47135,370,500Jul 08 09:35 PM
Harris ParkerCo-FounderJul 05Option Exercise27.065,000135,31337,620Jul 05 08:55 PM
Benioff MarcChairman of the Board & CEOJul 05Option Exercise27.0612,500338,28135,383,000Jul 08 09:35 PM
TOMLINSON LAWRENCEDirectorJul 05Sale79.051,600126,48028,629Jul 05 08:01 PM
Roos John VictorDirectorJul 05Sale79.0515512,25317,695Jul 05 08:05 PM
Harris ParkerCo-FounderJul 05Sale78.705,000393,50132,620Jul 05 08:55 PM
Benioff MarcChairman of the Board & CEOJul 05Sale78.7212,500983,95435,370,500Jul 08 09:35 PM
Benioff MarcChairman of the Board & CEOJul 01Option Exercise27.0612,500338,28135,383,000Jul 05 09:05 PM
Weaver Amy EEVP, General CounselJul 01Option Exercise59.349,381556,66919,910Jul 05 07:45 PM
Benioff MarcChairman of the Board & CEOJul 01Sale79.9612,500999,54635,370,500Jul 05 09:05 PM
Weaver Amy EEVP, General CounselJul 01Sale80.049,381750,83010,529Jul 05 07:45 PM
Benioff MarcChairman of the Board & CEOJun 30Option Exercise27.0612,500338,28135,383,000Jul 05 09:05 PM
Benioff MarcChairman of the Board & CEOJun 30Sale79.4912,500993,57935,370,500Jul 05 09:05 PM
TOMLINSON LAWRENCEDirectorJun 30Sale79.411,600127,05630,229Jun 30 08:23 PM
Benioff MarcChairman of the Board & CEOJun 29Option Exercise27.0612,500338,28135,383,000Jun 29 09:18 PM
Benioff MarcChairman of the Board & CEOJun 29Sale79.1012,500988,72735,370,500Jun 29 09:18 PM
Benioff MarcChairman of the Board & CEOJun 28Option Exercise27.0612,500338,28135,383,000Jun 29 09:18 PM
Harris ParkerCo-FounderJun 28Option Exercise27.065,000135,31337,620Jun 29 09:31 PM
Benioff MarcChairman of the Board & CEOJun 28Sale77.2212,500965,20835,370,500Jun 29 09:18 PM
TOMLINSON LAWRENCEDirectorJun 28Sale77.551,600124,08031,829Jun 28 08:43 PM
Robbins Cynthia G.EVP, Global Employee SuccessJun 28Sale77.555,000387,7502,226Jun 29 08:50 PM
Roos John VictorDirectorJun 28Sale77.5515512,02017,850Jun 29 08:54 PM
Harris ParkerCo-FounderJun 28Sale77.215,000386,04532,620Jun 29 09:31 PM
Benioff MarcChairman of the Board & CEOJun 27Option Exercise27.0612,500338,28135,383,000Jun 27 08:42 PM
Hawkins Mark JChief Financial OfficerJun 27Option Exercise59.648,624514,33516,029Jun 27 09:22 PM
Benioff MarcChairman of the Board & CEOJun 27Sale76.2212,500952,79335,370,500Jun 27 08:42 PM
Hawkins Mark JChief Financial OfficerJun 27Sale76.978,624663,8017,405Jun 27 09:22 PM
Weaver Amy EEVP, General CounselJun 24Option Exercise52.305,650295,49516,179Jun 27 08:35 PM
Benioff MarcChairman of the Board & CEOJun 24Option Exercise27.0612,500338,28135,383,000Jun 27 08:42 PM
Weaver Amy EEVP, General CounselJun 24Sale79.825,650450,96110,529Jun 27 08:35 PM
Martinez MariaPres., Sales & Cust. SuccessJun 24Sale79.752,390190,61128,704Jun 27 08:38 PM
Benioff MarcChairman of the Board & CEOJun 24Sale79.2712,500990,82435,370,500Jun 27 08:42 PM
BLOCK KEITHPres., Vice Chairman and COOJun 23Option Exercise37.9510,000379,50010,000Jun 23 06:42 PM
Benioff MarcChairman of the Board & CEOJun 23Option Exercise27.0612,500338,28135,383,000Jun 27 08:42 PM
BLOCK KEITHPres., Vice Chairman and COOJun 23Sale81.1110,000811,1000Jun 23 06:42 PM
Benioff MarcChairman of the Board & CEOJun 23Sale81.7812,5001,022,28335,370,500Jun 27 08:42 PM
Benioff MarcChairman of the Board & CEOJun 22Option Exercise27.0612,500338,28135,383,000Jun 22 09:18 PM
Benioff MarcChairman of the Board & CEOJun 22Sale80.9412,5001,011,70635,370,500Jun 22 09:18 PM
Harris ParkerCo-FounderJun 21Option Exercise27.065,000135,31337,620Jun 21 07:43 PM
BLOCK KEITHPres., Vice Chairman and COOJun 21Option Exercise37.9510,000379,50010,000Jun 22 09:09 PM
Benioff MarcChairman of the Board & CEOJun 21Option Exercise27.0612,500338,28135,383,000Jun 22 09:18 PM
Harris ParkerCo-FounderJun 21Sale81.555,000407,75532,620Jun 21 07:43 PM
BLOCK KEITHPres., Vice Chairman and COOJun 21Sale81.6210,000816,1810Jun 22 09:09 PM
Benioff MarcChairman of the Board & CEOJun 21Sale81.5612,5001,019,48035,370,500Jun 22 09:18 PM
Roos John VictorDirectorJun 21Sale81.5715512,64318,005Jun 22 08:46 PM
Benioff MarcChairman of the Board & CEOJun 20Option Exercise27.0612,500338,28135,425,000Jun 20 08:04 PM
Benioff MarcChairman of the Board & CEOJun 20Sale81.8012,5001,022,44035,412,500Jun 20 08:04 PM
Benioff MarcChairman of the Board & CEOJun 17Option Exercise27.0612,500338,28135,425,000Jun 20 08:04 PM
Benioff MarcChairman of the Board & CEOJun 17Sale80.5612,5001,007,06235,412,500Jun 20 08:04 PM
Benioff MarcChairman of the Board & CEOJun 16Option Exercise27.0612,500338,28135,425,000Jun 20 08:04 PM
BLOCK KEITHPres., Vice Chairman and COOJun 16Option Exercise37.9510,000379,50010,000Jun 20 08:09 PM
Benioff MarcChairman of the Board & CEOJun 16Sale81.0912,5001,013,56635,412,500Jun 20 08:04 PM
BLOCK KEITHPres., Vice Chairman and COOJun 16Sale81.1310,000811,3190Jun 20 08:09 PM
Benioff MarcChairman of the Board & CEOJun 15Option Exercise27.0612,500338,28135,425,000Jun 15 07:17 PM
Benioff MarcChairman of the Board & CEOJun 15Sale82.2112,5001,027,62935,412,500Jun 15 07:17 PM
Harris ParkerCo-FounderJun 14Option Exercise27.065,000135,31328,923Jun 14 08:16 PM
BLOCK KEITHPres., Vice Chairman and COOJun 14Option Exercise37.9510,000379,50010,000Jun 14 08:19 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-5.63 Insider Own0.10% Shs Outstand393.75M Perf Week2.67%
Market Cap98.04B Forward P/E14.38 EPS next Y17.31 Insider Trans- Shs Float393.75M Perf Month8.94%
Income-2446.20M PEG- EPS next Q3.32 Inst Own89.80% Short Float1.47% Perf Quarter8.66%
Sales16.30B P/S6.01 EPS this Y23.00% Inst Trans-0.05% Short Ratio1.62 Perf Half Y-16.46%
Book/sh183.69 P/B1.36 EPS next Y22.45% ROA- Target Price293.06 Perf Year-20.95%
Cash/sh5.77 P/C43.12 EPS next 5Y9.70% ROE- 52W Range195.50 - 340.34 Perf YTD-20.33%
Dividend- P/FCF- EPS past 5Y-50.40% ROI-1.30% 52W High-26.84% Beta0.68
Dividend %- Quick Ratio0.90 Sales past 5Y33.40% Gross Margin71.80% 52W Low27.36% ATR4.97
Employees31200 Current Ratio1.00 Sales Q/Q48.10% Oper. Margin- RSI (14)65.84 Volatility1.32% 2.07%
OptionableYes Debt/Eq0.59 EPS Q/Q86.30% Profit Margin- Rel Volume0.55 Prev Close247.84
ShortableYes LT Debt/Eq0.53 EarningsAug 08 BMO Payout- Avg Volume3.57M Price248.98
Recom1.90 SMA205.07% SMA505.57% SMA200-7.44% Volume1,960,400 Change0.46%
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Apr-06-16Downgrade Mizuho Buy → Neutral $330 → $250
Mar-31-16Reiterated Canaccord Genuity Buy $340 → $320
Feb-23-16Reiterated Mizuho Buy $354 → $330
Feb-23-16Reiterated Deutsche Bank Buy $308 → $339
Feb-19-16Initiated Wells Fargo Outperform
Nov-24-15Reiterated Mizuho Buy $340 → $354
Nov-13-15Reiterated Mizuho Buy $337 → $340
Oct-28-15Reiterated Leerink Partners Outperform $311 → $342
Oct-09-15Initiated Mizuho Buy
Sep-29-15Initiated Nomura Buy
Aug-07-15Reiterated RBC Capital Mkts Outperform $361 → $375
Aug-07-15Reiterated Deutsche Bank Buy $346 → $350
Jul-22-16 10:31AM  Investors scrap for Teva Pharmaceutical bonds Reuters
Jul-21-16 12:07PM  Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin at The Wall Street Journal
11:25AM  Amgen (AMGN) Stock Rises on 'Non-Inferior' Late-Stage Trial Results
10:39AM  Valeant & Endo: Imagining a World With No Drug Pricing Controversies at Barrons.com
10:16AM  Amgen, Allergan biosimilar found as effective as Roche cancer drug Reuters
09:00AM  Amgen And Allergan Announce Top-Line Results From Phase 3 Study Evaluating ABP 980 Compared With Trastuzumab In Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer PR Newswire
Jul-20-16 05:36PM  [$$] Jury Acquits Former Johnson & Johnson Unit Execs of Felony Fraud at The Wall Street Journal
03:31PM  Weitz Funds Comments on Allergan
01:56PM  Weitz Funds' 2nd Quarter 2016 Value Fund Commentary
01:56PM  Wally Weitz's Partners Value Fund 2Q 2016 Quarterly Commentary
07:59AM  Actress Marisa Tomei Partners with Allergan to Raise Awareness of Chronic Dry Eye PR Newswire
Jul-19-16 07:59AM  Allergan and Adamas Announce New Expanded Indication for NAMZARIC® (Memantine and Donepezil Hydrochlorides) Extended Release for the Treatment of Moderate to Severe Alzheimer's Disease PR Newswire
07:54AM  'Incredible' Demand for Teva's $15B Bond Deal Pushes Yields Lower at Barrons.com
02:19AM  Teva Pharm prices $15 bln in notes to fund Allergan generics deal Reuters
Jul-18-16 04:56PM  Edwards Lifesciences (EW) Q2 Earnings: Will It Be a Miss?
01:57PM  Allergan Files De Novo Application For Approval Of Oculeve Intranasal Tear Neurostimulator
01:21PM  [$$] Teva Finalizes Bond Sale at The Wall Street Journal
12:58PM  Outperform With A Crowded Positions Strategy
12:11PM  Teva ratchets in pricing on new benchmark bond Reuters
08:17AM  URGENT-Teva to sell up to seven-tranche US dollar bond Monday Reuters
08:05AM  Allergan Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator PR Newswire
Jul-15-16 03:13PM  Pfizer's Split: A Double-Edged Sword? at Forbes
02:10PM  Top 7 Research Reports for July 15, 2016
09:23AM  Teva Makes Good Use of Rate Climate to Fund Allergan deal
Jul-14-16 12:53PM  Turns out nobody ever really wanted Bill Ackman at Valeant
12:20PM  Why Tevas $20 Billion Bond Sale Makes Sense, as Long as Its a Fixed Rate at 24/7 Wall St.
08:10AM  Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain
01:18AM  Teva Surges on Robust Outlook, Allergan Deal at Bloomberg
Jul-13-16 07:28PM  Teva Pharmaceuticals shares up after it raises second-quarter estimates at CNBC
06:27PM  Ruane Cunniff Comments on Allergan
04:36PM  Teva Forecasts Growth After Expected Actavis Deal Closes
01:37PM  Welcome to the Hard Part, Teva at Bloomberg
01:02PM  US STOCKS-Wall St record-setting rally peters out
11:35AM  Teva says Allergan deal to close 'any time', expects U.S. antitrust clearance Reuters
11:04AM  How Will Recent Developments Affect Allergan?
10:55AM  Why the Teva Acquisition Proves It Is a Stock to Own for the Decade at 24/7 Wall St.
10:36AM  Why Traders Are Talking About Allergan, Teva, and 3 Other Stocks Today at Insider Monkey
10:13AM  Teva says Allergan deal to close 'any time' Reuters
09:51AM  Sequoia Fund Drops Valeant, Allergan and Cabela's
09:39AM  Allergan extends Teva deal deadline Reuters
09:27AM  Stocks to Watch: Diamondback Energy, Imprivata, American Airlines, Juno Therapeutics at The Wall Street Journal
09:25AM  [$$] Teva, Allergan Tweak Acquisition Agreement at The Wall Street Journal
09:04AM  How Does Allergans Financial Guidance Look for 2016?
07:47AM  Teva Raises Q2 Guidance; to Unveil 2016-2019 View
06:52AM  ALLERGAN PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
Jul-12-16 08:05PM  How Did Allergans Anda Distribution Segment Perform?
06:34PM  [$$] Teva Raises Guidance at The Wall Street Journal
05:11PM  Teva Lifts Q2 Guidance Ahead Of Post-Buyout Long-Term Forecast
04:04PM  Shire Stock Up As Eye Drug Wins Early Approval, Broad Label
01:24PM  Allergan Still Has More to Prove
09:34AM  [$$] Shire boosted by FDA approval of dry eye drug at Financial Times
09:07AM  How Did Allergans International Brands Segment Perform?
07:30AM  Allergan to Host Second Quarter 2016 Earnings Conference Call and Webcast PR Newswire
Jul-11-16 10:06PM  How Did Allergans US Medical Aesthetics Segment Perform?
09:34PM  FDA approves Shire's keenly-watched eye drug Reuters
09:06AM  How Did Allergans US Brands Segment Perform?
Jul-08-16 12:05PM  Pfizers Recent Corporate and Pipeline Developments
11:37AM  The Hypocrisy That's Turned Hedge Fund Activists Into Billionaires at Forbes
11:07AM  How Has Allergans Revenue Stream Changed in Recent Quarters?
10:47AM  How Will AstraZeneca (AZN) Stock Be Affected by Generic Copies?
09:07AM  Why Allergan Acquired Topokine Therapeutics?
06:33AM  Goldman Sachs Calls These Stocks Buys, but the Charts Disagree
Jul-07-16 08:05AM  Allergan Demonstrates a Strong Commitment to America's First Responders Donating Over $1 Million Worth of REFRESH® Eye Drops PR Newswire
Jul-06-16 06:43PM  Cramer: My biggest mistakes made investing at CNBC
12:07PM  Analyst Estimates for Pfizer: Why Should We Take Notice?
09:39AM  AstraZeneca Skin Drug, Tralokinumab, Rights Licensed to LEO
Jul-05-16 02:06PM  How Did Hedge Funds Favourite Healthcare Stocks Perform during Q2? at Insider Monkey
07:00AM  Juniper Pharmaceuticals Announces that Merck KGaA, Darmstadt, Germany, has Obtained Regulatory Approval for OneCrinone® in Japan PR Newswire
Jul-04-16 11:06AM  Insights into Pfizers Profitability and Financial Guidance
Jul-02-16 09:04AM  3 Issues That Every Healthcare Investor Should Consider at Motley Fool
08:05AM  3 Large-Cap Stocks to Buy in July at Motley Fool
12:01AM  [$$] Biotech Bargain at Barrons.com
Jul-01-16 03:52PM  Why a Hedge Fund Heavyweight Is Blasting Donald Trump on Trade
09:54AM  Biogen: Not Worth A Buy Unless It Buys
07:43AM  Allergan's 'double-chin' treatment gets positive opinion in Sweden at MarketWatch
07:30AM  Allergan Receives Positive Opinion Through European Decentralised Procedure For BELKYRA® (Deoxycholic Acid) For Patients With Submental Fullness PR Newswire
04:42AM  New Global Research from Allergan Shows New Attitude to Beauty as Women Seek Confidence Over Youth PR Newswire
Jun-30-16 04:24PM  Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016 at Motley Fool
07:00AM  Healthcare: Stock Selection Increasingly Important Morningstar
07:00AM  Healthcare: Stock Selection Increasingly Important at Morningstar
Jun-29-16 10:22AM  Pharma Combats Regulators With Smaller 'Tuck-In' Deals
01:34AM  Allergan's Plans for M&A and China
01:34AM  Allergan's Plans for M&A and China at Bloomberg
01:30AM  Allergan Seeks Smaller M&A for Growth After Pfizer Breakup at Bloomberg
Jun-28-16 05:35PM  Teva Inches Closer to Completion of Allergan Generics Deal
04:24PM  Think Healthcare M&A Is Dead? Think Again. at Motley Fool
02:20PM  Ahead of N.C. expansion, Mayne Pharma makes $652M generics play at bizjournals.com
11:27AM  [$$] Teva and Allergan Sell Generic Drugs to Impax In Latest Divestiture at The Wall Street Journal
08:48AM  Morning Movers: Dow Chemical Gains on Layoffs; Allergan Rises at Barrons.com
08:36AM  Mayne Pharma buys Teva drugs for $US652m AAP
07:49AM  Allergan Says New Research Indicates New Attitude To Beauty As Women Seek To Score Over Youth On Confidence
07:00AM  New Global Research From Allergan Shows New Attitude To Beauty As Women Seek Confidence Over Youth PR Newswire
07:00AM  New Global Research From Allergan Shows New Attitude To Beauty As Women Seek Confidence Over Youth CNW Group
06:05AM  Brexit Bargain Buys: 14 More Stocks Picked by Morgan Stanley
Jun-27-16 08:01PM  Mayne to Buy Generic Drugs From Allergan, Teva for $652 Million at Bloomberg
07:30PM  Mayne Pharma nears deal for Teva assets: source Reuters
06:08PM  Carl Icahn Says Allergan Is Undervalued, Takes a Large Position
05:55PM  Mayne Pharma nears deal for Teva assets -source Reuters
03:59PM  Allergan Plc Value Analysis (NYSE:AGN) : June 27, 2016
02:09PM  Allergan Has Rolled Over Again
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, and medical aesthetics, as well as dermatology and plastic surgery. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. Allergan plc also distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
ADBE Adobe Systems Incorporated daily Stock Chart
ADBE [NASD]
Adobe Systems Incorporated
IndexS&P 500 P/E55.40 EPS (ttm)1.77 Insider Own0.10% Shs Outstand499.97M Perf Week0.24%
Market Cap49.03B Forward P/E25.78 EPS next Y3.80 Insider Trans-96.09% Shs Float495.84M Perf Month4.31%
Income895.60M PEG1.97 EPS next Q0.72 Inst Own89.70% Short Float0.93% Perf Quarter3.45%
Sales5.31B P/S9.24 EPS this Y135.20% Inst Trans0.08% Short Ratio1.89 Perf Half Y9.41%
Book/sh14.50 P/B6.76 EPS next Y32.77% ROA7.60% Target Price111.68 Perf Year21.60%
Cash/sh8.64 P/C11.35 EPS next 5Y28.18% ROE12.70% 52W Range71.27 - 100.56 Perf YTD4.39%
Dividend- P/FCF30.88 EPS past 5Y-3.40% ROI7.40% 52W High-2.49% Beta1.27
Dividend %- Quick Ratio2.20 Sales past 5Y4.80% Gross Margin85.10% 52W Low37.59% ATR1.69
Employees13893 Current Ratio2.20 Sales Q/Q20.30% Oper. Margin22.40% RSI (14)54.29 Volatility1.59% 1.54%
OptionableYes Debt/Eq0.00 EPS Q/Q65.80% Profit Margin16.90% Rel Volume0.86 Prev Close96.34
ShortableYes LT Debt/Eq0.26 EarningsJun 21 AMC Payout0.00% Avg Volume2.44M Price98.06
Recom1.80 SMA202.31% SMA501.13% SMA2007.25% Volume2,101,500 Change1.79%
Jun-22-16Reiterated UBS Buy $114 → $122
Jun-22-16Reiterated Rosenblatt Buy $112 → $120
Apr-21-16Resumed Credit Suisse Neutral $85 → $105
Apr-12-16Reiterated FBR Capital Mkt Perform $100 → $115
Apr-04-16Reiterated Dougherty & Company Buy $116 → $122
Mar-31-16Initiated Canaccord Genuity Buy $110
Mar-18-16Reiterated Wunderlich Hold $94 → $99
Mar-18-16Reiterated UBS Buy $105 → $114
Mar-18-16Reiterated RBC Capital Mkts Outperform $101 → $104
Mar-18-16Reiterated Dougherty & Company Buy $114 → $116
Jan-14-16Initiated Dougherty & Company Buy $114
Dec-14-15Reiterated Argus Buy $95 → $110
Dec-11-15Reiterated Wunderlich Hold $90 → $94
Dec-11-15Reiterated RBC Capital Mkts Outperform $100 → $112
Dec-11-15Reiterated Pivotal Research Group Buy $95 → $104
Dec-11-15Reiterated KeyBanc Capital Mkts Overweight $90 → $110
Dec-11-15Reiterated JP Morgan Overweight $95 → $100
Dec-11-15Reiterated FBR Capital Mkt Perform $87 → $100
Dec-08-15Reiterated Deutsche Bank Buy $90 → $110
Oct-07-15Reiterated FBR Capital Mkt Perform $82 → $87
Jul-22-16 06:01PM  Here's How the Cloud is Helping Tech Stocks Win
08:45AM  Is Adobe Systems (ADBE) a Great Growth Stock?
08:24AM  Adobe Systems, Inc. breached its 50 day moving average in a Bearish Manner : ADBE-US : July 22, 2016
08:07AM  Massive Cluster of Insider Selling at Lennox International Inc. (LII) and 2 Other Well-Known Companies at Insider Monkey
Jul-21-16 04:44PM  Top-Rated Apple Supplier Leads 5 Stocks Poised To Break Out
03:11PM  [$$] Firefox Will Dump Adobe's Flash in August at The Wall Street Journal
01:19PM  These Top Stocks Could Soon Provide Buying Opportunities
01:18PM  Mozilla Joins Google and Facebook in Phasing Out Adobe Flash at Fortune
Jul-20-16 10:09AM  How These Artists Used Google Spreadsheet for Beauty Not Drudgery at Fortune
08:00AM  VMware (VMW) Catches Eye: Stock Adds 9% in Session
Jul-19-16 06:59PM  Intel's (INTC) Knights to Raid the Supercomputing Industry
11:52AM  ETFs with exposure to Adobe Systems, Inc. : July 19, 2016
Jul-15-16 04:32PM  Microsoft Wins Big in Cloud Privacy Protection Lawsuit
04:24PM  Facebook, Netflix, Smith & Wesson, Adobe Lead Week's Insider Trades
Jul-14-16 05:33PM  Intel's Open Source Alliance to Boost Security Solutions
11:49AM  Online prices actually point to deflation, not inflation at CNBC
09:12AM  Customers Happier With Second Amazon Prime Day at Motley Fool
07:00AM  Adobe Report Shows Continued Deflation in U.S. Economy Business Wire
Jul-13-16 09:00AM  A high-tech mecca rises to rival Silicon Valley at CNBC
08:59AM  Shutterstock Climbs On Google Ad Win at Barrons.com
08:45AM  SAP-APWorks Team Up to Accelerate Industrial 3D Printing
Jul-12-16 04:23PM  Shutterstock Jumps On Google Deal As Adobe Rivalry Grows
07:27AM  New Strong Buy Stocks for July 12th
Jul-11-16 06:46PM  Adobe to Offer Better Signature Security with Cloud Consortium
08:54AM  Add to Your Adobe Long Position at TheStreet
08:18AM  Adobe Systems, Inc. breached its 50 day moving average in a Bullish Manner : ADBE-US : July 11, 2016
Jul-10-16 12:00PM  CODING CAMPS! at San Jose Mercury News
12:00PM  Bay Area girls stream into summer coding camps at San Jose Mercury News
10:15AM  Huge Sheryl Sandberg Trade Highlights Furious Insider Selling: Facebook, Shake Shack, Adobe and More
Jul-09-16 08:04AM  A Close Look at Adobes Margins in Fiscal 2Q16
Jul-08-16 08:23AM  Adobe Trumpets Need for Digital Signature Standard at Fortune
05:22AM  The immense power of video advertising
05:22AM  The heritage and future of the Adobe brand
05:22AM  Online advertising: How not to alienate consumers
05:22AM  75% of Adobes marketing dollars go into digital
Jul-07-16 09:19AM  10 high-profile cyberhacks still impacting consumers today at CNBC
Jul-06-16 02:05PM  What Are Analyst Recommendations for Adobe Stock? at Market Realist
02:05PM  What Are Analysts Saying about Adobe Now? at Market Realist
01:04PM  ADOBE SYSTEMS INC Financials
Jul-05-16 04:10PM  ADBE: Top 4 Mutual Fund Holders of Adobe Systems at Investopedia
10:06AM  Adobe and Peers Continue to Lure Investors with Share Buybacks
10:05AM  Why Is Adobes Interest in Mobile App Development Good News?
09:09AM  Adobe Systems Incorporated (ADBE) Registers Notable Cluster of Insider Selling, Plus Two Other Companies with Insider Selling at Insider Monkey
Jul-01-16 07:30AM  CACI shifting focus from services to 'solutions.' Here's what that means. at bizjournals.com
Jun-30-16 09:19AM  What's Wrong With Adobe Systems Incorporated Stock? Absolutely Nothing at Motley Fool
09:09AM  Research Report Initiated on Select Application Software Equities
09:09AM  Research Report Initiated on Select Application Software Equities Company Spotlight
Jun-29-16 04:08PM  ADOBE SYSTEMS INC Files SEC form 10-Q, Quarterly Report
10:06AM  Adobe Is the Leader in Gartners Magic Quadrant, Again
Jun-28-16 05:05PM  Adobe Digital Marketing Performance in Fiscal 2Q16
04:08PM  Top Stock Picks for the Week of June 27th
01:05PM  Why Adobe Stock Fell after Fiscal 2Q16 Results
11:07AM  Adobe Marketing Cloud Continued Upward Trajectory in Fiscal 2Q16
09:08AM  Adobe and Other Tech Players Want More Digital Marketing Space
12:01AM  Adobe Rallies Industry to Drive Open Standard for Cloud-Based Digital Signatures Business Wire
Jun-27-16 02:06PM  New Stock Research Reports for June 27, 2016
02:05PM  How Adobes Digital Media Segment Helped It Post Growth in 2Q16
11:09AM  Here's Why Patient Growth Investors Will Be Richly Rewarded By Adobe at TheStreet
09:00AM  This VC who sold his last startup to Adobe just raised a $70 million fund in 3 months
08:58AM  Why Adobe Systems (ADBE) Could Be an Impressive Growth Stock
Jun-26-16 03:02PM  Cloud Growth Helps Adobe in 2nd Quarter Gurufocus
Jun-24-16 06:21PM  Brexit Bears Down On U.S. Stocks; Tesla Skids Hard For The Week
05:17PM  Week In Review: Brexit Shocks World; Tesla Stuns Fans; JPMorgan, BofA Stressed
05:10PM  Brexit Spoils Software M&A Lift: Salesforce, Adobe, Workday Fall at Investor's Business Daily
05:04PM  Salesforce.com, ServiceNow, Adobe 'Pricing Power' Spark Buy Ratings at Investor's Business Daily
04:56PM  A Look at Adobes Operating Segments in Fiscal 2Q16 at Market Realist
04:56PM  Adobe Enjoys Yet Another Successful Quarter in Fiscal 2Q16
04:40PM  Q2 Earnings Season Gets Underway
02:04PM  What Are the Top Stock Picks from Goldman Sachs?
12:15PM  Adobe (ADBE) Stock Initiated at 'Outperform' at Cowen and Co. at TheStreet
11:24AM  What Analysts Are Saying About Adobe After Earnings at 24/7 Wall St.
10:15AM  Apple, Home Depot Turn to Bloom Energy As Its Tech Advances at Fortune
Jun-23-16 06:00PM  Stocks Sag ahead of Brexit Vote
05:12PM  Apple Faces Uproar Over Rumored Removal Of Audio Jack From Next iPhone at Investor's Business Daily
11:35AM  How Analysts View Adobe After Earnings at 24/7 Wall St.
10:05AM  Why Was Salesforce Ready to Pay a Premium for Demandware? at Market Realist
Jun-22-16 10:09PM  Asian stocks mixed ahead of Britain's referendum -5.73%
06:45PM  Indexes See Downside Reversal; Tesla, Adobe Gap Down
06:20PM  Why Tesla Motors, Adobe Systems, and HP Slumped Today at Motley Fool
05:29PM  Apple's MacBook: Essentially, A 'Net Computer, Not a Netbook at Barrons.com
04:25PM  [$$] Adobe slides after lacklustre sales update at Financial Times
04:21PM  Stocks Fall Ahead Of Brexit; Tesla, FedEx Weigh
04:14PM  Adobe Systems Stock Drops On Sales Growth Concerns at Investor's Business Daily
04:10PM  Markets Right Now: Early gains fade, leaving stocks lower AP
03:11PM  Stocks Struggle for Direction as Oil Drops, McDonald's Drags on Dow
02:54PM  ExclusiveHow Donald Trump really earns his money
12:47PM  4 Stocks, 4 trades: FDX, KBH, ADBE & FB
12:15PM  Adobe (ADBE) Stock Slides on Soft Q3 Guidance at TheStreet
11:30AM  US STOCKS-Healthcare stocks boost Wall St
11:21AM  Tesla slides on $2.8B SolarCity deal; Adobe drops on outlook; Restoration Hardware buyout talk
11:20AM  Adobe Systems, Inc. :ADBE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016
11:10AM  Stocks Rise Despite Tesla, Adobe, FedEx; Priceline Near Buy
11:04AM  Stocks Rise as Yellen Points to Likely Transitory Economic Weakness
10:57AM  Cramer: Dont bet against Adobe at these levels at CNBC
10:11AM  Jim Cramer -- Don't Bet Against Adobe at TheStreet
09:48AM  US STOCKS-Wall St edges up ahead of Brexit vote
09:35AM  Stocks Open Higher; Tesla Dives, Solar City Beams Up On Merger Deal
09:23AM  Cramer's Mad Dash: Adobe down
09:22AM  Stocks to Watch: Tesla, SolarCity, QEP Resources at The Wall Street Journal
09:20AM  Adobe (ADBE) Beats Earnings and Revenue Estimates in Q2
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. Adobe Systems Incorporated has a strategic partnership with comScore, Inc. The company was founded in 1982 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DALEY JAMES EDirectorJul 20Option Exercise33.235,000166,15033,086Jul 21 04:08 PM
WARNOCK JOHN ECo-Chairman of the BoardJul 20Sale98.512,000197,024579,115Jul 21 04:10 PM
DALEY JAMES EDirectorJul 20Sale98.505,000492,50028,086Jul 21 04:08 PM
BARNHOLT EDWARD WDirectorJul 11Option Exercise37.0925,000927,25058,124Jul 11 05:56 PM
BARNHOLT EDWARD WDirectorJul 11Sale97.2525,0002,431,13333,124Jul 11 05:56 PM
Rencher BradleyEVP & GM, Digital MarketingJul 01Sale95.4637,5623,585,62747,269Jul 01 05:38 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJul 01Sale95.6827125,9291,348Jul 01 04:13 PM
LAMKIN BRYANEVP & GM, Digital MediaJul 01Sale95.049,616913,90523,665Jul 01 04:10 PM
WARNOCK JOHN ECo-Chairman of the BoardJun 30Sale95.154,000380,605581,115Jul 01 04:09 PM
ROSENSWEIG DANIELDirectorJun 29Sale92.9819,3001,794,57419,268Jul 11 04:57 PM
Lewnes AnnEVP, Chief Marketing OfficerJun 24Sale92.394,000369,56046,828Jun 24 04:32 PM
Lewnes AnnEVP, Chief Marketing OfficerMay 27Sale99.404,000397,59650,828May 31 04:09 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryMay 10Sale95.099,466900,16736,409May 11 04:17 PM
Lewnes AnnEVP, Chief Marketing OfficerApr 29Sale92.894,000371,56054,828May 02 04:29 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Option Exercise0.003,4260581,129Apr 14 04:49 PM
CALDERONI FRANKDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:47 PM
BARNHOLT EDWARD WDirectorApr 12Option Exercise0.003,426033,124Apr 14 04:45 PM
Desmond LauraDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:43 PM
BURGESS ROBERT KDirectorApr 12Option Exercise0.003,426038,124Apr 14 04:42 PM
Banse AmyDirectorApr 12Option Exercise0.003,426027,791Apr 14 04:36 PM
ROSENSWEIG DANIELDirectorApr 12Option Exercise0.003,426051,568Apr 14 04:34 PM
DALEY JAMES EDirectorApr 12Option Exercise0.003,426028,086Apr 14 04:32 PM
GESCHKE CHARLES MCo-Chairman of the BoardApr 12Option Exercise0.003,4260299,973Apr 14 04:27 PM
Barlow Kelly JDirectorApr 12Option Exercise0.003,42603,426Apr 13 06:23 PM
SEDGEWICK ROBERTDirectorApr 12Option Exercise0.003,426079,347Apr 13 05:22 PM
CANNON MICHAEL RDirectorApr 12Option Exercise0.003,426033,124Apr 13 05:20 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Sale93.295,000466,458577,703Apr 12 05:32 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 09Option Exercise0.002,81702,817Apr 12 05:34 PM
DALEY JAMES EDirectorApr 01Option Exercise33.825,000169,10029,660Apr 01 07:35 PM
NARAYEN SHANTANUPresident and CEOApr 01Option Exercise34.0322,422763,021321,394Apr 01 07:31 PM
NARAYEN SHANTANUPresident and CEOApr 01Sale94.8522,4222,126,678298,972Apr 01 07:31 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 01Sale95.058,780834,5500Apr 01 07:28 PM
DALEY JAMES EDirectorApr 01Sale95.005,000475,00024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 31Sale93.992,767,739260,127,4666,000Mar 31 05:43 PM
DALEY JAMES EDirectorMar 30Option Exercise33.822,84096,04927,500Apr 01 07:35 PM
DALEY JAMES EDirectorMar 30Sale94.002,840266,96024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 30Sale93.764,000,000375,040,0002,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 29Sale92.971,965,580182,739,9736,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 28Sale92.53100,0009,253,0008,739,319Mar 28 05:06 PM
ValueAct Holdings, L.P.DirectorMar 24Sale92.51821,80876,025,4588,839,319Mar 28 05:06 PM
ROWLEY RICHARDVP, Corp. Controller & CAOMar 24Sale92.464,146383,3498,780Mar 25 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceMar 22Sale93.0025,0002,325,00074,008Mar 23 04:38 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Option Exercise42.6125,0001,065,250321,547Mar 23 04:33 PM
WARNOCK JOHN ECo-Chairman of the BoardMar 21Sale92.709,000834,309587,703Mar 23 04:35 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Sale92.4825,0002,311,875296,547Mar 23 04:33 PM
Lewnes AnnEVP, Chief Marketing OfficerFeb 26Sale86.314,000345,23362,828Feb 29 06:02 PM
Lewnes AnnEVP, Chief Marketing OfficerFeb 03Option Exercise34.032,28077,58866,828Feb 05 04:14 PM
NARAYEN SHANTANUPresident and CEOFeb 01Option Exercise34.0322,422763,021321,394Feb 02 04:35 PM
NARAYEN SHANTANUPresident and CEOFeb 01Sale88.8022,4221,991,007298,972Feb 02 04:35 PM
ValueAct Holdings, L.P.DirectorJan 29Sale89.01185,00016,466,85011,773,739Feb 02 04:31 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 29Sale86.234,000344,90264,548Feb 01 04:37 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 29Sale86.2510,310889,28045,875Feb 01 04:31 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 26Sale86.8473,0006,338,99951,718Jan 27 04:34 PM
ValueAct Holdings, L.P.DirectorJan 25Sale89.005,000445,00011,958,739Jan 25 06:25 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 25Sale88.5253,3954,726,7490Jan 27 04:43 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 24Option Exercise0.00108,359078,348Jan 27 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJan 24Option Exercise0.0076,4750121,109Jan 27 04:41 PM
LAMKIN BRYANEVP & GM, Digital MediaJan 24Option Exercise0.0017,184027,464Jan 27 04:39 PM
Rencher BradleyEVP & GM, Digital MarketingJan 24Option Exercise0.00108,2000112,252Jan 27 04:36 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 24Option Exercise0.00149,3590169,665Jan 27 04:34 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 24Option Exercise0.0020,930017,893Jan 27 04:32 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 24Option Exercise0.0061,567074,673Jan 27 04:45 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 24Option Exercise0.0076,475090,649Jan 27 04:28 PM
ValueAct Holdings, L.P.DirectorJan 22Sale89.271,612,000143,903,24011,963,739Jan 25 06:25 PM
ValueAct Holdings, L.P.DirectorJan 21Sale89.56435,00038,958,60013,575,739Jan 25 06:25 PM
NARAYEN SHANTANUPresident and CEOJan 04Option Exercise34.0322,422763,021299,025Jan 05 04:33 PM
NARAYEN SHANTANUPresident and CEOJan 04Sale91.2422,4222,045,843276,603Jan 05 04:33 PM
NARAYEN SHANTANUPresident and CEODec 01Option Exercise34.0322,422763,021299,025Dec 02 04:16 PM
NARAYEN SHANTANUPresident and CEODec 01Sale91.8922,4222,060,308276,603Dec 02 04:16 PM
NARAYEN SHANTANUPresident and CEONov 02Option Exercise34.0322,422763,021299,025Nov 03 04:35 PM
NARAYEN SHANTANUPresident and CEONov 02Sale88.8522,4221,992,134276,603Nov 03 04:35 PM
DILLON MICHAEL ASVP, Gen. Counsel & SecretaryOct 29Sale88.125,000440,60825,173Oct 30 04:41 PM
Morris DonnaSVP, People and PlacesOct 26Sale88.0516,0001,408,80260,865Oct 27 04:31 PM
SEDGEWICK ROBERTDirectorOct 23Option Exercise23.2815,942371,13091,863Oct 23 07:06 PM
SEDGEWICK ROBERTDirectorOct 23Sale88.9815,9421,418,44375,921Oct 23 07:06 PM
DALEY JAMES EDirectorOct 22Option Exercise33.825,000169,10029,660Oct 23 07:08 PM
Rencher BradleySVP & GM, Digital MarketingOct 22Option Exercise34.1510,000341,47051,503Oct 23 07:11 PM
DALEY JAMES EDirectorOct 22Sale88.345,000441,67724,660Oct 23 07:08 PM
Rencher BradleySVP & GM, Digital MarketingOct 22Sale88.6626,0002,305,14225,503Oct 23 07:11 PM
DALEY JAMES EDirectorOct 15Option Exercise33.825,000169,10029,660Oct 16 06:16 PM
DALEY JAMES EDirectorOct 15Sale86.005,000430,00024,660Oct 16 06:16 PM
Lewnes AnnSVP, Chief Marketing OfficerOct 14Sale84.004,000336,00030,405Oct 15 04:15 PM
GESCHKE CHARLES MCo-Chairman of the BoardOct 13Sale84.004,699394,724296,547Oct 13 06:20 PM
GESCHKE CHARLES MCo-Chairman of the BoardOct 12Option Exercise28.8556,8871,641,079332,947Oct 13 06:20 PM
GESCHKE CHARLES MCo-Chairman of the BoardOct 12Sale84.1631,7012,667,988301,246Oct 13 06:20 PM
NARAYEN SHANTANUPresident and CEOOct 01Option Exercise34.0322,422763,021299,025Oct 02 04:46 PM
NARAYEN SHANTANUPresident and CEOOct 01Sale82.1222,4221,841,342276,603Oct 02 04:46 PM
Lewnes AnnSVP, Chief Marketing OfficerSep 09Sale80.794,000323,16034,405Sep 10 04:46 PM
NARAYEN SHANTANUPresident and CEOSep 01Option Exercise34.0322,422763,021299,025Sep 02 06:27 PM
NARAYEN SHANTANUPresident and CEOSep 01Sale76.6022,4221,717,577276,603Sep 02 06:27 PM
DILLON MICHAEL ASVP, Gen. Counsel & SecretaryAug 24Sale74.686,576491,09530,173Aug 25 04:05 PM
DILLON MICHAEL ASVP, Gen. Counsel & SecretaryAug 23Option Exercise0.0027,500051,098Aug 25 04:05 PM
GARRETT MARKEVP, CFO & Asst. SecretaryAug 17Sale86.4926,8992,326,6020Aug 18 04:13 PM
GARRETT MARKEVP, CFO & Asst. SecretaryAug 16Option Exercise0.0056,250056,250Aug 18 04:13 PM
NARAYEN SHANTANUPresident and CEOAug 03Option Exercise34.0322,422763,021299,025Aug 04 04:05 PM
NARAYEN SHANTANUPresident and CEOAug 03Sale81.9522,4221,837,543276,603Aug 04 04:05 PM
SEDGEWICK ROBERTDirectorJul 27Option Exercise42.6125,0001,065,250100,921Jul 27 05:55 PM
SEDGEWICK ROBERTDirectorJul 27Sale80.2725,0002,006,76575,921Jul 27 05:55 PM
SHPG Shire plc daily Stock Chart
SHPG [NASD]
Shire plc
Index- P/E28.68 EPS (ttm)6.75 Insider Own0.10% Shs Outstand300.35M Perf Week1.10%
Market Cap58.11B Forward P/E12.94 EPS next Y14.95 Insider Trans0.00% Shs Float279.92M Perf Month10.33%
Income1.33B PEG2.21 EPS next Q2.91 Inst Own20.50% Short Float0.69% Perf Quarter4.50%
Sales6.64B P/S8.76 EPS this Y-59.40% Inst Trans6.23% Short Ratio0.67 Perf Half Y6.60%
Book/sh52.20 P/B3.71 EPS next Y19.65% ROA7.00% Target Price245.21 Perf Year-25.58%
Cash/sh0.23 P/C842.24 EPS next 5Y13.00% ROE13.50% 52W Range146.98 - 269.34 Perf YTD-5.22%
Dividend1.33 P/FCF- EPS past 5Y16.50% ROI12.00% 52W High-28.16% Beta1.11
Dividend %0.69% Quick Ratio0.40 Sales past 5Y13.10% Gross Margin85.10% 52W Low31.64% ATR4.18
Employees5548 Current Ratio0.60 Sales Q/Q14.80% Oper. Margin22.40% RSI (14)58.49 Volatility1.07% 1.70%
OptionableYes Debt/Eq0.67 EPS Q/Q-0.90% Profit Margin19.80% Rel Volume0.29 Prev Close193.46
ShortableYes LT Debt/Eq0.45 EarningsAug 02 BMO Payout10.00% Avg Volume2.88M Price193.49
Recom1.70 SMA204.09% SMA505.64% SMA2004.49% Volume833,900 Change0.02%
Jun-03-16Reiterated Jefferies Buy $223 → $262
May-26-16Initiated Stifel Buy $230
May-06-16Initiated Liberum Buy
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-10-16Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $240
Feb-10-16Initiated Guggenheim Neutral
Jan-15-16Upgrade BofA/Merrill Neutral → Buy
Jan-12-16Upgrade Credit Suisse Neutral → Outperform
Jan-12-16Reiterated RBC Capital Mkts Sector Perform $248 → $240
Nov-17-15Upgrade Leerink Partners Mkt Perform → Outperform $239
Nov-03-15Upgrade HSBC Securities Hold → Buy
Oct-26-15Reiterated RBC Capital Mkts Sector Perform $263 → $248
Oct-14-15Initiated Northland Capital Outperform $288
Sep-30-15Upgrade HSBC Securities Reduce → Hold
Aug-06-15Downgrade Exane BNP Paribas Outperform → Neutral
Jul-16-15Resumed Berenberg Buy
Apr-29-15Initiated Exane BNP Paribas Outperform
Jan-26-15Reiterated RBC Capital Mkts Sector Perform $238 → $248
Jan-12-15Reiterated RBC Capital Mkts Sector Perform $221 → $238
Oct-15-14Upgrade CRT Capital Fair Value → Buy $225
Jul-25-16 02:01AM  Merrimack Announces ONIVYDE® Regimen Receives Positive CHMP Opinion in European Union PR Newswire
02:00AM  ONIVYDE® Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy PR Newswire
Jul-22-16 01:07PM  Inside Lillys 2Q16 Estimates for Its Neuroscience Franchise
Jul-21-16 04:41PM  How Analysts Think Investors Should Play Vertex Pharmaceuticals
10:39AM  Valeant & Endo: Imagining a World With No Drug Pricing Controversies at Barrons.com
07:00AM  Shire Launches Pediatric Indication for Immunodeficiency Treatment HyQvia in Europe PR Newswire
Jul-20-16 01:21PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jul-19-16 07:00AM  Shire Reinforces Commitment in Hematology with Robust Data Presented at International Congress of the World Federation of Hemophilia PR Newswire
Jul-14-16 03:10PM  Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta
08:56AM  Coverage Initiated on Select Healthcare Stocks
Jul-13-16 10:10AM  Company News for July 13, 2016
09:05AM  Regenerons Dupilumab: How Much Potential Does It Hold?
Jul-12-16 08:44PM  Multimedia assets now available: FDA Approves Shire's Xiidra (lifitegrast ophthalmic solution) 5% - The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease PR Newswire
08:20PM  Shire's (SHPG) Dry Eye Disease Drug Xiidra Gets FDA Nod
05:24PM  Shire shares up after US approves dry-eye disease treatment at CNBC
04:04PM  Shire Stock Up As Eye Drug Wins Early Approval, Broad Label
12:29PM  Five Stocks That Have Investors Excited Today at Insider Monkey
11:10AM  Shire Gains Key FDA Approval in Dry Eye Treatment
10:31AM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
09:34AM  [$$] Shire boosted by FDA approval of dry eye drug at Financial Times
05:29AM  Shires Shares Rise on FDA Approval of Dry Eye Med
03:55AM  Shire Surges After FDA Approves Xiidra for Dry-Eye Disease
Jul-11-16 09:34PM  FDA approves Shire's keenly-watched eye drug Reuters
08:20PM  FDA Approves Shire's Dry-Eye Treatment at The Wall Street Journal
07:08PM  Regulatory Approval - FDA Approves Shires Xiidra (lifitegrast ophthalmic solution) 5% The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease PR Newswire
11:36AM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jul-08-16 06:36PM  Shire (SHPG) Gets EU Nod for Label Expansion of Revestive
Jul-07-16 02:00AM  Shire Receives Extension of Market Authorization in Europe for Revestive (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS) PR Newswire
Jul-06-16 02:06PM  Understanding the Valuation Catalysts for BioMarin in 4Q16
Jul-05-16 12:12PM  5 Best Bets for the Q2 Earnings Season
Jul-01-16 04:52PM  10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate?
04:30PM  Shire Stock Up Despite Mixed Data on Pipeline Candidate
12:19PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jun-30-16 04:44PM  Shire Stock Up As Premature Infant Treatment Yields Mixed Results
03:01PM  How Is Horizon Pharma Looking on a Price-to-Sales Basis?
01:25PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:06PM  Why ConAgra Foods, Hertz Global, Shire PLC and Two Other Stocks Are on the Move Today at Insider Monkey
09:57AM  Shire stock up 1.3% after premature infant treatment meets secondary endpoints in midstage trial at MarketWatch
07:00AM  Shire Announces Top-Line Results for Phase 2 Trial of SHP607 in Extremely Premature Infants PR Newswire
01:59AM  UPDATE 1-Shire says ADHD drug meets main goal of study (June 29)
Jun-29-16 12:37PM  [$$] Shire Reports Encouraging Results for ADHD Drug at The Wall Street Journal +5.65%
08:15AM  Shire says ADHD drug meets main goal of study
07:12AM  Shire's stock surges after ADHD drug trial meets key endpoints at MarketWatch
07:00AM  Shire Announces Positive Topline Results of SHP465 Efficacy and Safety Study in Adults With ADHD PR Newswire
Jun-28-16 10:06AM  Will Lifitegrast Be Approved in 2016?
09:27AM  Shire and Glaxo Offer Prescription to London's Woes
Jun-22-16 09:07AM  What Is Shires Outlook for 2016?
Jun-21-16 03:23PM  Will Lifitegrast Be Approved in 2016?
Jun-20-16 08:57AM  Biotech stocks are in for more election trouble on drug pricing at MarketWatch
Jun-16-16 06:00AM  'Mad Money' Lightning Round: I'm Sticking With Southwest Airlines
Jun-15-16 05:19PM  Shire Buys Global Rights to Pfizer's Gastrointestinal Drug
03:25PM  [$$] Allergan, Teva Set to See Catalysts at Barrons.com
01:56PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:45AM  Why Best Buy, Celgene, and Three Other Stocks Are Making Headlines Today at Insider Monkey
07:00AM  Shire and Kamada Announce FDA Approval of Expanded Label for Self-infusion of GLASSIA for the Treatment of Emphysema Due To Severe AAT Deficiency PR Newswire
Jun-14-16 06:18PM  Shire Gets Breakthrough Status for Rare Disease Candidates
02:03PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:30PM  Smith & Wesson Giving Back Yesterdays Gains, Plus 4 Other Sinking Stocks at Insider Monkey
09:55AM  Stocks Mixed; Investor Day Forecast Lifts Alibaba
07:25AM  Drugmaker Shire buys bowel drug rights from Pfizer
07:00AM  Shire to License PF-00547659 from Pfizer, Adding to Established and Leading Gastrointestinal Portfolio PR Newswire
Jun-13-16 08:30AM  With Brexit Looming, Hedge Funds Weigh In On British Stocks at Insider Monkey
07:00AM  Shire Receives FDA Breakthrough Therapy Designation for SHP621 and SHP625, Investigational Products for Rare Gastrointestinal Conditions PR Newswire
Jun-10-16 03:10PM  Shire Announces Completion of Decentralized Procedure in Europe for Immunoglobulin Treatment Cuvitru PR Newswire
12:12PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jun-08-16 08:25AM  4 Top Jefferies Value Stocks to Buy With Big Upside Potential at 24/7 Wall St.
Jun-07-16 02:46PM  Why Is Mylan So High on Trastuzumab Biosimilar Data?
01:50PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jun-06-16 05:20PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:02PM  Shire plc -- Moody's downgrades Baxalta to Baa3; stable outlook at Moody's
Jun-04-16 12:13AM  Five ADRs Hedge Funds Are Bullish On: Baidu, Shire, JD.Com, More at Insider Monkey
Jun-03-16 05:32PM  Shire Closes Baxalta Buyout, Sparking Higher Growth Forecast
04:11PM  SHIRE PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of
11:23AM  Shire (SHPG) Stock Climbing on Baxalta Acquisition
08:10AM  Shire completes Baxalta acquisition, creating state's biggest pharma company at bizjournals.com
08:00AM  Shire to Participate at Two Upcoming Investor Conferences PR Newswire
03:40AM  Shire Completes Combination With Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions PR Newswire
Jun-01-16 02:16PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
11:58AM  5 Top ROE Stocks to Profit in Turbulent Times
May-31-16 04:19PM  Shires Shareholders Approve Baxalta Merger: Whats Next?
10:30AM  Shire (SHPG) Gets Favorable CHMP Opinion for Revestive
May-27-16 05:50PM  TransDigm Group Set to Join the S&P 500; Helen of Troy and Brocade Communications Systems to Join S&P MidCap 400; Team and MDC Holdings to Join S&P SmallCap 600 PR Newswire
11:52AM  SHIRE PLC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
11:23AM  Shire Expects to Wrap Up Baxalta Buy on June 3
10:00AM  CORRECTING and REPLACING Baxalta Shareholders Vote to Approve Combination Business Wire
02:00AM  Shire Receives Positive CHMP Opinion in Europe for Revestive® (Teduglutide) for Paediatric Patients with Short Bowel Syndrome PR Newswire
May-26-16 07:28AM  Coverage initiated on Shire plc by Stifel
06:38AM  5 Health Care Stocks Whose Charts Tell You to Wait to Buy
May-25-16 02:19PM  Why 58.com Inc (ADR) (WUBA)s Stock Is Trending on Wednesday? at Insider Monkey
May-24-16 06:53AM  5 Health Care Stocks John Paulson Is Betting On in 2016
May-23-16 10:53AM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
06:02AM  CF Industries Pulls $8 Billion Takeover of OCI Assets
May-20-16 12:06PM  ETFs with exposure to Shire Plc : May 20, 2016
11:27AM  Specialty Pharma Stocks are CheapBut Only Some are Worth Buying at Barrons.com
May-19-16 01:18PM  Swedish-Born Tom Sandell Focuses on Equity Special Events Opportunities at Insider Monkey
May-17-16 05:04PM  5 Foreign Stocks Worth Investing Post-Q1 Earnings
May-12-16 03:15PM  As Shire-Baxalta merger nears, lots of unanswered questions remain at bizjournals.com
May-11-16 03:00PM  Shire to Present New Research at 2016 American Psychiatric Association Annual Meeting PR Newswire
01:04PM  SHIRE PLC Financials
May-10-16 02:29PM  Epizyme (EPZM) Reports Narrower-than-Expected Q1 Loss Zacks
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment